WO2014178501A1 - Functional cosmetic composition comprising enzymatic hydrolysate of tilapia mossambica scales - Google Patents

Functional cosmetic composition comprising enzymatic hydrolysate of tilapia mossambica scales Download PDF

Info

Publication number
WO2014178501A1
WO2014178501A1 PCT/KR2013/010020 KR2013010020W WO2014178501A1 WO 2014178501 A1 WO2014178501 A1 WO 2014178501A1 KR 2013010020 W KR2013010020 W KR 2013010020W WO 2014178501 A1 WO2014178501 A1 WO 2014178501A1
Authority
WO
WIPO (PCT)
Prior art keywords
tilapia
scales
hydrolyzate
cosmetic composition
test
Prior art date
Application number
PCT/KR2013/010020
Other languages
French (fr)
Korean (ko)
Inventor
문영섭
안용석
문창훈
고창익
Original Assignee
(주)청룡수산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)청룡수산 filed Critical (주)청룡수산
Publication of WO2014178501A1 publication Critical patent/WO2014178501A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Definitions

  • the present invention relates to a cosmetic composition
  • a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia ( Tilapia Mossambica ) scales, and more particularly to a functional cosmetic composition having antioxidant, anti-wrinkle and whitening effects comprising the ingredient as an active ingredient. .
  • Cosmetics refers to all things used for make-up, such as creams and lotions. Cosmetics prescribed by the Pharmacist Act are "articles used by painting, spraying or other similar methods to clean or beautify the human body. It is defined as, “and at the same time, products that are regulated in all aspects, including manufacturing, sales, and advertising.
  • Cosmetics with various functions such as cosmetics to moisturize the skin, cosmetics to reduce the size of pores, cosmetics to remove dead skin cells, cosmetics to relieve wrinkles and cosmetics with whitening function are being released.
  • the demand for the same functional cosmetics is expected to continue to increase.
  • Kim et al. (1993) succeeded in industrializing extracting useful gelatin from tilapia, and extracting collagen from tilapia scales to produce and sell some of them for food and medicine.
  • the production of peptides from food proteins using proteolytic enzymes is known to be applied to the production of fish skin gelatin hydrolysates and convert them into useful components having physiological activity.
  • the problem to be solved in the present invention is to provide a functional cosmetic composition comprising an enzymatic hydrolyzate extracted from tilapia scales.
  • the present invention provides a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia mossambica scale extract.
  • the enzymatic hydrolyzate is dried (S1) tilapia scales in far infrared rays after washing with water; (S2) hydrothermally extracting the dried tilapia scales; (S3) enzymatic hydrolysis of the hydrothermally extracted tilapia scales; (S4) activated carbon filtration of the enzymatic hydrolyzate of the tilapia scales; (S5) filtering the activated carbon filtrate with a 0.4 to 0.5 ⁇ m filtration membrane; (S6) filtering the filtrate by the filter membrane of 0.4 ⁇ 0.5 ⁇ m with an ion exchange resin membrane; (S7) fractionating the ion exchange resin membrane filtrate into an ultrafiltration membrane; And (S8) is preferably prepared comprising the step of lyophilization and pulverization of the fractions.
  • the enzymatic hydrolysis is preferably selected from the group consisting of ⁇ -chymotrypsin, alcalase, kojozyme, protamex and trypsin.
  • the cosmetic composition preferably exhibits antioxidant, anti-wrinkle and whitening effects.
  • the enzymatic hydrolyzate of tilapia scales which is an active ingredient of the present invention, exhibits excellent effects on antioxidant activity, wrinkle improvement and whitening, and is suitable for use as a functional cosmetic composition as it is harmless to the human body as a natural material.
  • FIG. 1 shows a tilapia scale extraction process chart.
  • T1 is ⁇ -chymotrypsin enzyme hydrolyzate
  • P1 is ⁇ 5kDa Ultrafiltration fraction
  • P2 represents ⁇ 10 kDa ultrafiltration fraction
  • P3 represents ⁇ 30 kDa ultrafiltration fraction.
  • T1 is ⁇ -chymotrypsin enzyme hydrolyzate
  • P1 is Ultrafiltration fraction of ⁇ 5 kDa
  • P2 represents ⁇ 10 kDa ultrafiltration fraction
  • P3 represents ⁇ 30 kDa ultrafiltration fraction.
  • Figure 8 is the result of measuring the Elastinase inhibition in order to confirm the anti-wrinkle effect of enzymatic hydrolysates of tilapia scales
  • T1 is the ⁇ -chymotrypsin enzyme hydrolyzate
  • P1 is ⁇ 5kDa ultrafiltration
  • the filtration fraction, P2, represents ⁇ 10 kDa ultrafiltration fraction
  • P3 represents ⁇ 30 kDa ultrafiltration fraction.
  • Figure 9 is the result of measuring the tyrosinase inhibition to confirm the whitening activity of the enzymatic hydrolyzate of tilapia scales
  • T1 is the ⁇ -chymotrypsin enzyme hydrolyzate
  • P1 is ⁇ 5 kDa ultrafiltration Fraction
  • P2 represents ⁇ 10 kDa ultrafiltration fraction
  • P3 represents ⁇ 30 kDa ultrafiltration fraction.
  • Figure 10a to 10h shows the manufacturing process of the essence, nourishing cream, body lotion, rinse, shampoo, body cleanser, lotion, skin comprising the cosmetic composition of the present invention, respectively.
  • FIG. 11A to 11E are photographs showing representative steps of the manufacturing process of the mask pack including the genuine composition of the present invention.
  • 19 to 23 show the results of the overall efficacy analysis of the test group with the essence of the present invention.
  • the inventors of the present invention confirmed that the enzymatic hydrolyzate obtained from the tilapia scales had antioxidant activity, anti-wrinkle effect and whitening activity, and developed enzymatic hydrolyzate of tilapia scales having such activity for the use of functional cosmetic composition. It was.
  • the present invention provides a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia mossambica scale extract.
  • Tilapia a freshwater fish native to Southeast Africa, is said to have been farmed in Egypt for about 2,000 years.
  • the first scientific farming was carried out in Kenya in 1924 and soon spread throughout Africa, to the East in the 1940s, and to North America in the 50s.
  • breeding is carried out in more than 100 countries around the world, and was introduced to the Republic of Korea in May 1955 through the Inland Water Research Institute in Thailand.
  • the species transplanted to Korea are Oreochromis niloticus and Oreochromis mossambicus , which are collectively called tilapia. Since it is used as an alternative to red dome, it is also known as reverse dome and freshwater dome depending on the region. In Korean Walk, it is said that it is transplanted in Thailand and it is written as 'Taerae'.
  • the limit of aquaculture water temperature includes all kinds in the range of 14-45 degreeC, and the optimum water temperature range is 24-32 degreeC.
  • the optimum water temperature range is 24-32 degreeC.
  • the water temperature is maintained above 21 °C, it keeps spawning and the male makes spawning ground at the bottom and attracts the female to spawn.
  • the fertilized egg is hatched by the female.
  • the enzymatic hydrolyzate of the tilapia scales of the present invention comprises (S1) drying the tilapia scales with far infrared rays after washing with water; (S2) hydrothermally extracting the dried tilapia scales; (S3) enzymatic hydrolysis of the hydrothermally extracted tilapia scales; (S4) activated carbon filtration of the enzymatic hydrolyzate of the tilapia scales; (S5) filtering the activated carbon filtrate with a 0.4 to 0.5 ⁇ m filtration membrane; (S6) filtering the filtrate by the filter membrane of 0.4 ⁇ 0.5 ⁇ m with an ion exchange resin membrane; (S7) fractionating the ion exchange resin membrane filtrate into an ultrafiltration membrane; And (S8) is preferably prepared comprising the step of lyophilization and pulverization of the fractions.
  • Tilapia scales are easily available throughout Korea, and are preferably used to obtain enzymatic hydrolysates after washing and drying with fresh water. As for the drying, it is effective to use far infrared rays.
  • the enzymatic hydrolyzate may be obtained by treating the tilapia scales with a proteolytic enzyme as it is, or by first extracting the tilapia scales by hydrothermal extraction and treating the hydrothermal extract with a proteolytic enzyme. In order to increase the yield of the hydrolyzate, it is preferable to perform hydrothermal extraction first.
  • the conditions of hot water extraction are not particularly limited, but preferably 1 to 5 hours at 100 ° C, more preferably 3 hours at 100 ° C.
  • Proteolytic enzymes that may be used in the present invention include, for example, ⁇ -chymotrypsin, alcalase, kojizyme, protamex, trypsin, and the like. But preferably ⁇ -chymotrypsin or alcalase. Hydrolysis conditions are not particularly limited, but may be subjected to hydrolysis for 3 to 24 hours at the optimum pH and temperature of each enzyme.
  • the hydrolyzate is filtered using activated charcoal to remove off-flavor and peculiar color after hydrolysis.
  • the filtration method using activated carbon may be any known one.
  • the hydrolyzate which has undergone such multi-step filtration, is fractionated according to the molecular weight using an ultrafiltration membrane, and it is preferable to obtain a fraction having a molecular weight of 5kDa, 10kDa and 30kDa through the ultrafiltration membrane.
  • the molecular weight distribution of the enzymatic hydrolyzate of tilapia scales showing antioxidant activity, wrinkle improvement and whitening activity varies from 5 kDa or less to 30 kDa.
  • the molecular weight of the enzymatic hydrolyzate suitable for the cosmetic composition of the present invention is most preferably 5 kDa or less.
  • Fractions obtained through the above process is dried through a concentration process, and then stored until milled.
  • the cosmetic composition of the present invention may be prepared in the form of, for example, an essence, nutrition cream, body lotion, rinse, shampoo, body cleanser, lotion, skin, mask pack, and the like, but is not limited thereto. Preparation in this form may be readily performed according to various manufacturing processes known to those skilled in the art.
  • Tilapia scales were obtained from Cheongryong Fisheries Co., Ltd. located in Seogwipo-si, Jeju-do, and used after washing with fresh water.
  • Moisture, crude protein, crude fat and ash of the dried tilapia scales were measured. According to the AOAC method, the moisture content was measured by 105 ° C atmospheric pressure drying method with a significant difference of 0.002 g or less as a constant amount, and the crude protein content was measured by the Micro Kjeldahl method, and the ash content was measured by the dry method.
  • the moisture content was 2.6 ⁇ 0.01
  • the ash content was 0.3 ⁇ 0.01
  • the crude protein content was 97.06 ⁇ 0.1
  • the remaining components were 0.04 ⁇ 0.01.
  • the result shows that the protein content of tilapia scales of the same freshwater fish is very high. From this, it can be seen that the high content of protein contained in tilapia scales can be usefully used in the protein raw material industry.
  • dried tilapia scales were prepared by enzymatic hydrolysates of tilapia scales under the appropriate conditions corresponding to the enzymes by using five proteolytic enzymes in the following two methods.
  • tilapia scales were hydrolyzed directly using enzymes without hot water extraction. That is, 10 g of tilapia scales were mixed with 100 ml of distilled water, and then, each enzyme was added and hydrolyzed over time (3, 6, 12, 18, 24 hours) at the optimum pH and temperature for each enzyme.
  • the hydrolyzate prepared according to each method described above was boiled at 100 ° C. for 10 minutes to stop the enzyme reaction, and after adjusting the pH to neutral, the supernatant was separated by centrifugation (3500 rpm, 10 minutes) and vacuum filtration. The separated supernatant was lyophilized and used as a sample.
  • the degree of hydrolysis of enzymatic hydrolysates derived from tilapia scales was measured by TCA (trichloroacetic acid) method.
  • TCA trichloroacetic acid
  • the reaction mixture after the reaction was centrifuged (12000 rpm, 15 minutes) to take 2 ml from the supernatant, 20% TCA was added thereto in the same amount, centrifuged (3500 rpm, 10 minutes), and then a predetermined amount of the supernatant was removed.
  • 10% TCA soluble nitrogen was measured by Lowry method, and the degree of hydrolysis was calculated from the following equation.
  • hydrolyzates prepared by enzymatic hydrolysis showed a significantly higher degree of hydrolysis than those produced by enzymes alone.
  • the degree of hydrolysis rapidly increased up to 6 hours except for ⁇ -chymotrypsin, and the degree of hydrolysis remained constant thereafter.
  • hydrolyzate prepared by ⁇ -chymotrypsin showed a continuous increase in degree of hydrolysis up to 12 hours, and showed a high degree of hydrolysis of about 55% at 12 hours of hydrolysis (FIG. 3).
  • hydrolysis was performed according to the substrate-to-enzyme ratio and substrate concentration of the ⁇ -chymotrypsin enzymatic hydrolyzate.
  • Substrate-to-enzyme ratios were 10, 20, 50, 100, 200, 500 (weight / weight) and enzymatic hydrolyzate concentrations of the substrate, tilapia scales, were 1%, 3%, 5%, 10%, and 20%.
  • the hydrolysis was carried out in the same manner as the method presented above, and the degree of hydrolysis of the hydrolyzate was measured for the examination of all hydrolysis conditions.
  • the ⁇ -chymotrypsin hydrolyzate of the tilapia scales was first filtered through an activated carbon filtration membrane, and then secondarily filtered through a 0.45 ⁇ m diameter filtration membrane. Next, the filtrate was filtered through an ion exchange resin membrane in 3rd order to obtain a final filtrate.
  • the filtrate of tilapia enzymatic hydrolyzate treated with ⁇ -chymotrypsin was 5 kDa or less, 10 kDa or less, using an ultrafiltration membrane using 5 kDa, 10 kDa, 30 kDa membranes. Each fraction below 30 kDa was prepared.
  • DPPH is a stable model of free radicals. It can be seen that DPPH reduction during the reaction proceeds to scavenging free radicals and predicts the inhibition of the initial reaction of lipid peroxidation. Active oxygen, called harmful oxygen, is known to attack unsaturated fatty acids, which are components of cell membranes, to induce lipid peroxidation reactions and to accumulate lipid peroxides in the body, resulting in deterioration of biological function and aging and adult diseases. Antioxidant activity by plant components and extracts has been reported. In addition, H 2 O 2 is also a representative active oxygen can be measured the degree of antioxidant reaction to the extent of reduction of H 2 O 2 .
  • collagen and elastin form the network structure and maintain the elasticity of the skin.
  • the elasticity and the luster decrease due to internal and external stress such as age and ultraviolet rays, and the elastin mesh is caused by the overexpressed elastinase. If the structure is broken, the skin sags and wrinkles are generated, resulting in skin aging. Therefore, skin aging can be suppressed by inhibiting the activity of elastinase, which is an enzyme of elastin, one of the main causes of skin aging.
  • the tilapia scale enzymatic hydrolyzate and each ultrafiltration fraction of the present invention can be seen to exhibit excellent elastinase inhibitory activity.
  • the inhibitory activity of tyrosinase was measured using the method of Fuller.
  • 40 ⁇ l of 1.5mM trysine (sigma) solution was added to the solution and reacted at 37 ° C. for 10-15 minutes, and the absorbance was measured at 490 nm using an ELISA reader (TECAN, AT / sunrise R / C, Switzerland).
  • 0.1 M phosphate buffer (pH 6.5) was used instead of the sample solution as the blank sample solution.
  • Melanin synthesis is based on tyrosine, one of the amino acids, and the reaction after 3,4-dihydroxyphenylalanin (DOPA) and DOPA quinone by tyrosinase is largely pheomelanin, which determines reddish brown or yellow color, and eumelanin, which determines brown to brown color. It is divided into, and whitening effect can be expected by inhibiting melanin production by inhibiting the activity of tyrosinase, a major enzyme of melanin production.
  • DOPA 3,4-dihydroxyphenylalanin
  • OBJECTIVES To investigate the toxic response of a single oral dose of Tilapia scale enzyme hydrolyzate as a test substance in male and female Sprague-Dawley rats.
  • the group consisted of 2,000 mg / kg of test substance and 2 groups of control group (injection water), and five male and female mice were orally administered once. For 14 days after administration, general symptoms and body weights were observed, and euthanized by euthanasia at the end of the observation period. No deaths were observed in the 2,000 mg / kg male and female groups. In addition, the effects of test substance administration on general symptoms, body weight and necropsy were not recognized. As a result of a single oral administration of tilapia scale enzyme hydrolyzate to rats under the conditions of this test, the approximate lethal dose is estimated to be greater than 2,000 mg / kg of male and female.
  • test substance tilapia scale enzyme hydrolyzate was examined using three 16-week-old male NZW rabbits. The administration sites of the left and right each 2 sites and the sum 4 sites were set to the back of the rabbit, and 2 of them were irradiated and the other 2 were used as abrasion sites. 0.5 g of the test substance raw material was applied to each non-abrasive and abrasion site for 24 hours to blockage patch. The skin response was assessed according to Draize's Skin Response Evaluation Table at 24, 48 and 72 hours after dosing, and the primary skin irritation index (PII) was determined for 24 and 72 hours after dosing to determine skin irritation. .
  • PII primary skin irritation index
  • Eye irritation testing of test substance tilapia scale enzyme hydrolyzate was reviewed using six 16-week-old male NZW rabbits.
  • 0.1 g of test substance was injected into three rabbits' right eye conjunctival sac, and eye lesions such as cornea, iris and conjunctiva were observed at 1, 24, 48 and 72 hours after administration.
  • the face wash group was additionally administered in the same manner as the non-wash face group using three animals, and after washing for 30 seconds after administration, the face wash effect was confirmed.
  • the eye irritation of the test substance was evaluated according to the grade of the eye lesion of Draize, and the degree of eye irritation was classified by referring to Guillot's eye irritation evaluation table.
  • the test substance tilapia scale enzyme hydrolyzate under this test condition is judged to be non-irritant to the ocular mucosa of rabbits.
  • test substance group was firstly sensitized by intradermal administration of 50% test substance, and secondly sensitized by 100% test substance for 48 hours.
  • test substance tilapia scale enzyme hydrolyzate under this test condition is judged to be a substance without skin sensitization.
  • test substance group (5) The test substance group (5), negative control group (5) and positive control group (5). 22 cm of administration sites were set on the right and left sides of the guinea-pig skin of the test substance group, the negative control group, and the positive control group. 90% test substance was applied to the test substance group, water for injection to the negative control group, and 0.1% 8-Methoxypsoralen (8-MOP) to the positive control group was applied to each administration site.
  • UV-A was irradiated so that the final energy was about 10 J / cm 2 with the light irradiation site on the left side and the non-light irradiation site on the right side.
  • Skin reactions were evaluated 24, 48 and 72 hours after light irradiation, and the presence or absence of phototoxicity was determined. Skin reactions such as erythema and edema were not observed in all animals at 24, 48 and 72 hours after irradiation at 90% of the test substance dose. At all observation times at the injection site of the negative control group, no skin reactions such as erythema and edema were observed in all animals.
  • Stripping, open coating of the administration material, and UV-A irradiation were performed once a day for 5 consecutive days.
  • Yagi was caused by UV-A irradiation on day 21 after administration of 90% test substance and water for injection in test substance and negative control group and 0.1% CP and ethanol in positive control group.
  • Skin reactions were evaluated 24 and 48 hours after firing light irradiation. In the test substance group and the negative control group, skin reactions such as erythema and edema were not observed in all animals at 24 and 48 hours after the irradiated light irrespective of the irradiated area of 90% test substance and water for injection.
  • Cosmetics in the form of essences, nourishing creams, body lotions, rinses, shampoos, body cleansers, lotions, skins and mask packs were prepared comprising the tilapia scale hydrolyzate and ultrafiltration fractions of the present invention. Specific manufacturing processes are shown in FIGS. 10A to 10H and 11A to 11E.
  • the purpose of this study is to evaluate the wrinkle-improving effect and skin safety of the product by using the test product for 12 weeks in women who are 30 years old or older or who have already developed wrinkles.
  • wrinkles begin to be produced in accordance with SMA of the Dermatological Institute of Dermatology, or those who have indicated their intention to explain the purpose and method, expected efficacy and adverse reactions of the test should be filled out. Participated in the test.
  • Evaluation was performed by visual evaluation of crow's feet before and after 4, 8, and 12 weeks of product use and measurement of skin wrinkle parameters (R-value) using Skin Visiometer® SV600 (C + K, Germany), VISIA®. (Canfield, USA) was used to evaluate skin wrinkle improvement and skin safety by taking photographs, evaluating subjects, and investigator observation and questionnaires.
  • the comparison between groups at each time point was confirmed by correcting the difference between two groups before using the product using covariance analysis (ANCOVA), and the before and after comparison was confirmed using RM ANOVA.
  • ANCOVA covariance analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition comprising an enzymatic hydrolysate of Tilapia mossambica scales and, more particularly, to a functional cosmetic composition, having anti-oxidation, anti-wrinkle and whitening effects, comprising the ingredients as active ingredients. The enzymatic hydrolysate of Tilapia mossambica scales, which are active ingredients of the present invention, shows excellent antioxidant activity, anti-wrinkle and whitening effects, and is, as a natural material, harmless to the human body, and thus is suitable for a use of the functional cosmetic composition.

Description

틸라피아 비늘의 효소적 가수분해물을 포함하는 기능성 화장품 조성물Functional cosmetic composition comprising enzymatic hydrolyzate of tilapia scales
본 발명은 틸라피아(Tilapia Mossambica) 비늘의 효소적 가수분해물을 포함하는 화장품 조성물에 관한 것으로서, 보다 구체적으로는 상기 성분을 유효성분으로 포함하는 항산화, 주름개선 및 미백 효과를 갖는 기능성 화장품 조성물에 관한 것이다.The present invention relates to a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia ( Tilapia Mossambica ) scales, and more particularly to a functional cosmetic composition having antioxidant, anti-wrinkle and whitening effects comprising the ingredient as an active ingredient. .
화장품이란 크림, 로션 등 화장하는데 쓰이는 모든 물건을 지칭하는 것으로서 약사법에서 정해진 화장품은 "인체를 청결 또는 미화하기 위하여 도찰(塗擦), 살포 기타 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 적은 것을 말한다."라고 정의되어 있으며, 그와 동시에 제조, 판매, 그에 따르는 광고 등 모든 면에 규제를 받는 상품이다.Cosmetics refers to all things used for make-up, such as creams and lotions. Cosmetics prescribed by the Pharmacist Act are "articles used by painting, spraying or other similar methods to clean or beautify the human body. It is defined as, "and at the same time, products that are regulated in all aspects, including manufacturing, sales, and advertising.
최근 피부에 대한 관심이 높아짐에 따라 다양한 기능을 갖는 기능성 화장품에 대한 연구가 계속되고 있다. 피부에 수분을 공급하기 위한 화장품, 모공의 크기를 줄이기 위한 화장품, 피부 각질을 제거하기 위한 화장품, 주름을 완화시키기 위한 화장품, 미백기능을 갖는 화장품 등 다양한 기능을 가진 화장품들이 출시되고 있으며, 앞으로도 이와 같은 기능성 화장품의 수요는 계속 증가할 것으로 예측된다.Recently, as the interest on the skin increases, researches on functional cosmetics having various functions continue. Cosmetics with various functions such as cosmetics to moisturize the skin, cosmetics to reduce the size of pores, cosmetics to remove dead skin cells, cosmetics to relieve wrinkles and cosmetics with whitening function are being released. The demand for the same functional cosmetics is expected to continue to increase.
한편, 대부분의 어류 가공시 어류 가공부산물이 어체 중의 약 75% 정도로 발생하게 되고, 그 중 어류 뼈나 껍질이 약 30% 정도를 차지하고 있다. 따라서, 어류 가공시 발생되는 가공부산물을 이용하여 젤라틴이나 콜라겐과 같은 새로운 유용한 성분들을 분리하는 기술 개발은 매우 중요하다고 할 수 있다.On the other hand, when processing most fish, by-products of fish processing occur about 75% of the fish body, of which fish bones and shells account for about 30%. Therefore, it is very important to develop a technology for separating new useful components such as gelatin and collagen using processed by-products generated during fish processing.
이전 연구에서 Kim et al.(1993)은 틸라피아로부터 유용한 젤라틴을 추출하여 산업화에 성공하였으며, 틸라피아의 비늘로부터 콜라겐을 추출하여 식품 및 의약품용으로 일부 생산 판매하고 있다. 또한, 단백질 가수분해효소를 이용한 식품 단백질로부터 펩티드의 제조는 어류 껍질 젤라틴 가수분해물 제조 등에 응용되어 생리활성을 가지는 유용 성분으로 전환시키는 것으로 알려져 있다.In a previous study, Kim et al. (1993) succeeded in industrializing extracting useful gelatin from tilapia, and extracting collagen from tilapia scales to produce and sell some of them for food and medicine. In addition, the production of peptides from food proteins using proteolytic enzymes is known to be applied to the production of fish skin gelatin hydrolysates and convert them into useful components having physiological activity.
하지만, 아직까지 틸라피아 비늘을 이용하여 생리활성을 연구한 결과는 없으며, 틸라피아 비늘 유래의 가수분해물 제조에 대한 연구도 부족한 실정이다. 이와 같은 점에서, 가공부산물인 틸라피아 비늘을 이용하여 유용 성분을 추출하고 이를 기능성 화장품의 소재로서 사용하고자 하는 것은 매우 유용한 것이라 할 수 있다.However, there have been no studies on physiological activity using tilapia scales, and research on the preparation of hydrolyzate derived from tilapia scales is insufficient. In this regard, it is very useful to extract useful ingredients using tilapia scales, which are processed by-products, and to use them as materials for functional cosmetics.
본 발명에서 해결하려는 과제는 틸라피아 비늘로부터 추출된 효소적 가수분해물을 포함하는 기능성 화장품 조성물을 제공하고자 하는 것이다.The problem to be solved in the present invention is to provide a functional cosmetic composition comprising an enzymatic hydrolyzate extracted from tilapia scales.
상기와 같은 과제를 해결하기 위하여, 본 발명은 틸라피아(Tilapia mossambica) 비늘 추출물의 효소적 가수분해물을 포함하는 화장품 조성물을 제공한다.In order to solve the above problems, the present invention provides a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia mossambica scale extract.
상기 효소적 가수분해물은 (S1) 틸라피아 비늘을 수세 후 원적외선으로 건조시키는 단계; (S2) 건조된 틸라피아 비늘을 열수 추출하는 단계; (S3) 열수 추출된 틸라피아 비늘을 효소적 가수분해시키는 단계; (S4) 틸라피아 비늘의 효소적 가수분해물을 활성탄 여과시키는 단계; (S5) 활성탄 여과물을 0.4~0.5μm의 여과막으로 여과시키는 단계; (S6) 0.4~0.5μm의 여과막에 의한 여과물을 이온교환수지막으로 여과시키는 단계; (S7) 이온교환수지막 여과물을 한외여과막으로 분획하는 단계; 및 (S8) 분획물을 농축 후 동결건조 및 분쇄하는 단계를 포함하여 제조되는 것이 바람직하다.The enzymatic hydrolyzate is dried (S1) tilapia scales in far infrared rays after washing with water; (S2) hydrothermally extracting the dried tilapia scales; (S3) enzymatic hydrolysis of the hydrothermally extracted tilapia scales; (S4) activated carbon filtration of the enzymatic hydrolyzate of the tilapia scales; (S5) filtering the activated carbon filtrate with a 0.4 to 0.5 μm filtration membrane; (S6) filtering the filtrate by the filter membrane of 0.4 ~ 0.5μm with an ion exchange resin membrane; (S7) fractionating the ion exchange resin membrane filtrate into an ultrafiltration membrane; And (S8) is preferably prepared comprising the step of lyophilization and pulverization of the fractions.
상기 효소적 가수분해는 α-키모트립신(α-chymotrypsin), 알칼라아제(alcalase), 코지자임(Kojozyme), 프로타멕스(Protamex) 및 트립신(Trypsin)으로 이루어지는 군으로부터 선택되는 것이 바람직하다.The enzymatic hydrolysis is preferably selected from the group consisting of α-chymotrypsin, alcalase, kojozyme, protamex and trypsin.
상기 화장품 조성물은 항산화, 주름개선 및 미백 효과를 나타내는 것이 바람직하다.The cosmetic composition preferably exhibits antioxidant, anti-wrinkle and whitening effects.
본 발명의 유효성분인 틸라피아 비늘의 효소적 가수분해물은 항산화 활성, 주름 개선 및 미백에 우수한 효과를 나타내며, 천연 재료로서 인체에 무해하여 기능성 화장품 조성물의 용도로서 사용하기에 적합하다.The enzymatic hydrolyzate of tilapia scales, which is an active ingredient of the present invention, exhibits excellent effects on antioxidant activity, wrinkle improvement and whitening, and is suitable for use as a functional cosmetic composition as it is harmless to the human body as a natural material.
도 1은 틸라피아 비늘 추출 공정도를 나타낸다.1 shows a tilapia scale extraction process chart.
도 2는 틸라피아 비늘을 다양한 효소로 처리하여 얻어진 효소적 가수분해물의 가수분해도를 측정한 결과이다.2 is a result of measuring the degree of hydrolysis of the enzymatic hydrolyzate obtained by treating tilapia scales with various enzymes.
도 3은 틸라피아 비늘을 열수 추출한 후, 다양한 효소로 처리하여 얻어진 효소적 가수분해물의 가수분해도를 측정한 결과이다.3 is a result of measuring the degree of hydrolysis of the enzymatic hydrolyzate obtained by treatment with various enzymes after hot water extraction of tilapia scales.
도 4는 기질/효소 처리 농도별 틸라피아 비늘 α-키모트립신 가수분해물의 가수분해 정도를 측정한 결과이다.4 is a result of measuring the degree of hydrolysis of tilapia scale α-chymotrypsin hydrolyzate according to substrate / enzyme concentration.
도 5는 기질 농도별 틸라피아 비늘 α-키모트립신 가수분해물의 가수분해 정도를 측정한 결과이다.5 is a result of measuring the degree of hydrolysis of the tilapia scale α-chymotrypsin hydrolyzate according to the substrate concentration.
도 6은 틸라피아 비늘의 효소적 가수분해물의 항산화 활성을 확인하기 위하여 DPPH radical scavenging activity를 측정한 결과로서, T1은 틸라피아 비늘의 α-키모트립신(α-chymotrypsin) 효소 가수분해물, P1은 < 5kDa의 한외 여과 분획물, P2는 < 10kDa 한외 여과 분획물 및 P3는 < 30 kDa 한외 여과 분획물을 나타낸다. 6 is a result of measuring the DPPH radical scavenging activity in order to confirm the antioxidant activity of the enzymatic hydrolyzate of tilapia scales, T1 is α-chymotrypsin enzyme hydrolyzate, P1 is <5kDa Ultrafiltration fraction, P2 represents <10 kDa ultrafiltration fraction and P3 represents <30 kDa ultrafiltration fraction.
도 7은 틸라피아 비늘의 효소적 가수분해물의 항산화 활성을 확인하기 위하여 H2O2 radical scavenging activity를 측정한 결과이고, T1은 틸라피아 비늘의 α-키모트립신(α-chymotrypsin) 효소 가수분해물, P1은 < 5kDa의 한외 여과 분획물, P2는 < 10kDa 한외 여과 분획물 및 P3는 < 30 kDa 한외 여과 분획물을 나타낸다. 7 is a result of measuring the H 2 O 2 radical scavenging activity in order to confirm the antioxidant activity of the enzymatic hydrolyzate of tilapia scales, T1 is α-chymotrypsin enzyme hydrolyzate, P1 is Ultrafiltration fraction of <5 kDa, P2 represents <10 kDa ultrafiltration fraction and P3 represents <30 kDa ultrafiltration fraction.
도 8은 틸라피아 비늘의 효소적 가수분해물의 주름개선 효과를 확인하기 위하여 Elastinase inhibition을 측정한 결과이고, T1은 틸라피아 비늘의 α-키모트립신(α-chymotrypsin) 효소 가수분해물, P1은 < 5kDa의 한외 여과 분획물, P2는 < 10kDa 한외 여과 분획물 및 P3는 < 30 kDa 한외 여과 분획물을 나타낸다. Figure 8 is the result of measuring the Elastinase inhibition in order to confirm the anti-wrinkle effect of enzymatic hydrolysates of tilapia scales, T1 is the α-chymotrypsin enzyme hydrolyzate, P1 is <5kDa ultrafiltration The filtration fraction, P2, represents <10 kDa ultrafiltration fraction and P3 represents <30 kDa ultrafiltration fraction.
도 9는 틸라피아 비늘의 효소적 가수분해물의 미백활성을 확인하기 위하여 tyrosinase inhibition을 측정한 결과이고, T1은 틸라피아 비늘의 α-키모트립신(α-chymotrypsin) 효소 가수분해물, P1은 < 5kDa의 한외 여과 분획물, P2는 < 10kDa 한외 여과 분획물 및 P3는 < 30 kDa 한외 여과 분획물을 나타낸다. Figure 9 is the result of measuring the tyrosinase inhibition to confirm the whitening activity of the enzymatic hydrolyzate of tilapia scales, T1 is the α-chymotrypsin enzyme hydrolyzate, P1 is <5 kDa ultrafiltration Fraction, P2 represents <10 kDa ultrafiltration fraction and P3 represents <30 kDa ultrafiltration fraction.
도 10a 내지 도 10h는 본 발명의 화장품 조성물을 포함하는 에센스, 영양크림, 바디로션, 린스, 샴푸, 바디클렌저, 로션, 스킨의 제조 공정을 각각 나타낸 것이다.Figure 10a to 10h shows the manufacturing process of the essence, nourishing cream, body lotion, rinse, shampoo, body cleanser, lotion, skin comprising the cosmetic composition of the present invention, respectively.
도 11a 내지 도 11e는 본 발명의 화정품 조성물을 포함하는 마스크팩의 제조 공정의 대표적인 단계를 사진으로 나타낸 것이다.11A to 11E are photographs showing representative steps of the manufacturing process of the mask pack including the genuine composition of the present invention.
도 12 및 도 13은 본 발명의 에센스를 바른 시험군의 육안으로 평가된 변화의 분석 결과를 나타낸 것이다.12 and 13 show the results of analysis of changes visually evaluated in the test group with the essence of the present invention.
도 14 내지 도 18은 본 발명의 에센스를 바른 시험군의 주름 파라미터 분석 결과를 나타낸 것이다.14 to 18 show the wrinkle parameter analysis results of the test group with the essence of the present invention.
도 19 내지 도 23은 본 발명의 에센스를 바른 시험군의 전체적인 효능 분석 결과를 나타낸 것이다.19 to 23 show the results of the overall efficacy analysis of the test group with the essence of the present invention.
도 24는 본 발명의 에센스를 바른 시험군의 사용성에 대한 만족도를 보여주는 결과이다.24 is a result showing the satisfaction with the usability of the test group with the essence of the present invention.
이하, 본 발명을 상세하게 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.
본 발명의 발명자들은 틸라피아 비늘로부터 얻어진 효소적 가수분해물이 항산화 활성, 주름개선 효과 및 미백 활성을 가진다는 점을 확인하고, 이러한 활성을 가진 틸라피아 비늘의 효소적 가수분해물을 기능성 화장품 조성물의 용도로 개발하였다.The inventors of the present invention confirmed that the enzymatic hydrolyzate obtained from the tilapia scales had antioxidant activity, anti-wrinkle effect and whitening activity, and developed enzymatic hydrolyzate of tilapia scales having such activity for the use of functional cosmetic composition. It was.
따라서, 본 발명은 틸라피아(Tilapia mossambica) 비늘 추출물의 효소적 가수분해물을 포함하는 화장품 조성물을 제공한다.Accordingly, the present invention provides a cosmetic composition comprising an enzymatic hydrolyzate of Tilapia mossambica scale extract.
틸라피아는 아프리카 동남부가 원산지인 민물고기로, 이집트에서 약 2천여 년 전부터 양식하여 왔다고 기록되어 있다. 과학적인 양식은 1924년 케냐에서 처음으로 실시되어 곧 아프리카 전역으로 확산되었으며, 1940년대에는 동양으로, 50년대에는 북미 등으로 이식되었다. 현재는 전세계 100여 개국에서 사육이 이루어지고 있으며 대한민국에는 1955년 5월에 태국에서 내수면연구소를 통해 도입되었다.Tilapia, a freshwater fish native to Southeast Africa, is said to have been farmed in Egypt for about 2,000 years. The first scientific farming was carried out in Kenya in 1924 and soon spread throughout Africa, to the East in the 1940s, and to North America in the 50s. Currently, breeding is carried out in more than 100 countries around the world, and was introduced to the Republic of Korea in May 1955 through the Inland Water Research Institute in Thailand.
대한민국에 이식된 종은 Oreochromis niloticusOreochromis mossambicus이며, 이들 종을 합쳐서 일반적으로 틸라피아라고 부른다. 붉은돔의 대체어로 이용되므로 지역에 따라 역돔, 민물돔이라고도 한다. 「한국어도보」에서는 태국에서 이식되었다 하여 '태래어(泰來漁)'라고 적고 있다. The species transplanted to Korea are Oreochromis niloticus and Oreochromis mossambicus , which are collectively called tilapia. Since it is used as an alternative to red dome, it is also known as reverse dome and freshwater dome depending on the region. In Korean Walk, it is said that it is transplanted in Thailand and it is written as 'Taerae'.
1983년 Ethelwynn Trewavas에 의해 Tilapia, Sarotherodon, Oreochromis의 3속으로 분류되고 있으며, 전세계적으로 아종을 포함하여 총 100여 종이 알려져 있다. 환경 저항성이 강하며 성장이 빠르고 저급질의 사료로도 양식이 가능하여 해마다 생산량이 증가하고 있다.In 1983, Ethelwynn Trewavas was classified into three genera, Tilapia, Sarotherodon, and Oreochromis. A total of 100 species, including subspecies, are known worldwide. Due to its high environmental resistance, fast growth and low-quality feed, aquaculture is increasing year by year.
서식수온의 한계는 14∼45℃의 범위에 대체로 모든 종류가 포함되고, 최적수온 범위는 24∼32℃이다. 일반적으로 어릴 때는 동물성 먹이를 주로 먹으며, 성장함에 따라 식성이 식물성이나 잡식성으로 변한다. 수온이 21℃ 이상 유지되면 계속 산란하며 수컷이 바닥에 산란장을 만들고 암컷을 유인하여 산란한다. 수정된 알은 암컷이 입 속에 넣어 부화시킨다.The limit of aquaculture water temperature includes all kinds in the range of 14-45 degreeC, and the optimum water temperature range is 24-32 degreeC. In general, when they are young, they eat mainly animal food, and as they grow, their diet becomes vegetable or omnivorous. When the water temperature is maintained above 21 ℃, it keeps spawning and the male makes spawning ground at the bottom and attracts the female to spawn. The fertilized egg is hatched by the female.
본 발명의 틸라피아 비늘의 효소적 가수분해물은 (S1) 틸라피아 비늘을 수세 후 원적외선으로 건조시키는 단계; (S2) 건조된 틸라피아 비늘을 열수 추출하는 단계; (S3) 열수 추출된 틸라피아 비늘을 효소적 가수분해시키는 단계; (S4) 틸라피아 비늘의 효소적 가수분해물을 활성탄 여과시키는 단계; (S5) 활성탄 여과물을 0.4~0.5μm의 여과막으로 여과시키는 단계; (S6) 0.4~0.5μm의 여과막에 의한 여과물을 이온교환수지막으로 여과시키는 단계; (S7) 이온교환수지막 여과물을 한외여과막으로 분획하는 단계; 및 (S8) 분획물을 농축 후 동결건조 및 분쇄하는 단계를 포함하여 제조되는 것이 바람직하다.The enzymatic hydrolyzate of the tilapia scales of the present invention comprises (S1) drying the tilapia scales with far infrared rays after washing with water; (S2) hydrothermally extracting the dried tilapia scales; (S3) enzymatic hydrolysis of the hydrothermally extracted tilapia scales; (S4) activated carbon filtration of the enzymatic hydrolyzate of the tilapia scales; (S5) filtering the activated carbon filtrate with a 0.4 to 0.5 μm filtration membrane; (S6) filtering the filtrate by the filter membrane of 0.4 ~ 0.5μm with an ion exchange resin membrane; (S7) fractionating the ion exchange resin membrane filtrate into an ultrafiltration membrane; And (S8) is preferably prepared comprising the step of lyophilization and pulverization of the fractions.
틸라피아 비늘은 대한민국 전역에서 용이하게 입수할 수 있으며, 입수 후 담수로 세척하여 건조시킨 후 효소적 가수분해물을 얻는데 사용하는 것이 바람직하다. 상기 건조는 원적외선을 이용하는 것이 효과적이다.Tilapia scales are easily available throughout Korea, and are preferably used to obtain enzymatic hydrolysates after washing and drying with fresh water. As for the drying, it is effective to use far infrared rays.
상기 효소적 가수분해물은 틸라피아 비늘을 그대로 단백질 분해 효소로 처리하여 얻거나, 또는 틸라피아 비늘을 먼저 열수 추출하고, 열수추출물에 단백질 분해 효소를 처리하여 얻을 수 있다. 가수분해물의 수득율을 높이기 위하여는 열수 추출을 먼저 수행하는 것이 바람직하다. 열수 추출의 조건은 특별히 제한되지는 않으나, 바람직하게는 100℃에서 1~5시간, 더욱 바람직하게는 100℃에서 3시간 동안 추출한다.The enzymatic hydrolyzate may be obtained by treating the tilapia scales with a proteolytic enzyme as it is, or by first extracting the tilapia scales by hydrothermal extraction and treating the hydrothermal extract with a proteolytic enzyme. In order to increase the yield of the hydrolyzate, it is preferable to perform hydrothermal extraction first. The conditions of hot water extraction are not particularly limited, but preferably 1 to 5 hours at 100 ° C, more preferably 3 hours at 100 ° C.
본 발명에 사용될 수 있는 단백질 분해 효소는 예를 들어, α-키모트립신(α-chymotrypsin), 알칼라아제(alcalase), 코지자임(Kojizyme), 프로타멕스(protamex), 트립신(trypsin) 등을 들 수 있으나, 바람직하게는 α-키모트립신 또는 알칼라아제이다. 가수분해 조건은 특별히 제한되지는 않으나, 각 효소의 최적 pH 및 온도에서 3~24시간 동안 가수분해 반응을 시킬 수 있다.Proteolytic enzymes that may be used in the present invention include, for example, α-chymotrypsin, alcalase, kojizyme, protamex, trypsin, and the like. But preferably α-chymotrypsin or alcalase. Hydrolysis conditions are not particularly limited, but may be subjected to hydrolysis for 3 to 24 hours at the optimum pH and temperature of each enzyme.
가수분해물은 활성탄을 사용하여 여과시키는데, 이는 가수분해 후에 생기는 이취와 특유의 색을 제거하기 위함이다. 활성탄을 사용하는 여과 방법은 공지의 것이라면 어떠한 것이라도 무방하다.The hydrolyzate is filtered using activated charcoal to remove off-flavor and peculiar color after hydrolysis. The filtration method using activated carbon may be any known one.
활성탄 여과 후에는 다시 직경 0.4~0.5μm의 여과막을 통하여 이물질 등을 제거하는 공정을 거치고, 가수분해물 내에 잔존할지도 모르는 중금속이나 기타 이물질들을 완전히 제거하기 위하여 이온교환수지막을 이용한 여과를 수행한다.After activated carbon filtration, foreign matters are removed through a filtration membrane of 0.4 to 0.5 μm in diameter, and filtration using an ion exchange resin membrane is performed to completely remove heavy metals or other foreign substances that may remain in the hydrolyzate.
이와 같은 다단계의 여과 과정을 거친 가수분해물은 한외여과막을 사용하여 분자량에 따라 분획하는데, 5kDa, 10kDa 및 30kDa의 분자량을 갖는 분획물을 한외여과막을 통하여 얻는 것이 바람직하다. 항산화 활성, 주름개선, 미백 활성을 나타내는 틸라피아 비늘의 효소적 가수분해물의 분자량 분포는 5kDa 이하로부터 30kDa까지 다양한데, 본 발명의 화장품 조성물로 적합한 효소적 가수분해물의 분자량은 5kDa이하인 것이 가장 바람직하다.The hydrolyzate, which has undergone such multi-step filtration, is fractionated according to the molecular weight using an ultrafiltration membrane, and it is preferable to obtain a fraction having a molecular weight of 5kDa, 10kDa and 30kDa through the ultrafiltration membrane. The molecular weight distribution of the enzymatic hydrolyzate of tilapia scales showing antioxidant activity, wrinkle improvement and whitening activity varies from 5 kDa or less to 30 kDa. The molecular weight of the enzymatic hydrolyzate suitable for the cosmetic composition of the present invention is most preferably 5 kDa or less.
위와 같은 공정을 거쳐 얻어진 분획물은 농축과정을 거쳐 건조되며, 이후 분쇄하여 사용될 때까지 보관한다.Fractions obtained through the above process is dried through a concentration process, and then stored until milled.
본 발명의 화장품 조성물은 예를 들어, 에센스, 영양크림, 바디로션, 린스, 샴푸, 바디클렌저, 로션, 스킨, 마스크팩 등의 형태로 제조될 수 있으며, 여기에 한정되는 것은 아니다. 상기 형태로의 제조는 당업자에게 알려진 다양한 제조 공정에 따라 용이하게 수행될 수 있을 것이다.The cosmetic composition of the present invention may be prepared in the form of, for example, an essence, nutrition cream, body lotion, rinse, shampoo, body cleanser, lotion, skin, mask pack, and the like, but is not limited thereto. Preparation in this form may be readily performed according to various manufacturing processes known to those skilled in the art.
이하에서는 구체적인 실시예를 통하여 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail with reference to specific examples.
[실시예]EXAMPLE
1. 재료1. Material
틸라피아 비늘은 제주도 서귀포시에 위치한 (주)청룡수산에서 입수하였으며, 담수를 이용하여 수세 후 사용하였다.Tilapia scales were obtained from Cheongryong Fisheries Co., Ltd. located in Seogwipo-si, Jeju-do, and used after washing with fresh water.
2. 틸라피아 비늘의 일반 성분 측정2. Determination of common components of tilapia scales
건조된 틸라피아 비늘의 수분, 조단백질, 조지방 및 회분을 측정하였다. AOAC 방법에 준하여 수분 함량은 0.002g 이하의 유의차를 항량으로 하여 105℃ 상압가열건조법으로 측정하였고, 조단백질 함량은 Micro Kjeldahl법으로 측정하였으며, 회분 함량은 건식법으로 측정하였다.Moisture, crude protein, crude fat and ash of the dried tilapia scales were measured. According to the AOAC method, the moisture content was measured by 105 ° C atmospheric pressure drying method with a significant difference of 0.002 g or less as a constant amount, and the crude protein content was measured by the Micro Kjeldahl method, and the ash content was measured by the dry method.
표 1
성분 측정값(%)
조단백질 97.06±0.1
수분 2.6±0.01
회분 0.3±0.01
기타 0.04±0.01
Table 1
ingredient Measures(%)
Crude protein 97.06 ± 0.1
moisture 2.6 ± 0.01
Ash 0.3 ± 0.01
Other 0.04 ± 0.01
표 1에 제시된 바와 같이, 수분 함량은 2.6±0.01, 회분 함량은 0.3±0.01이고, 조단백질 함량은 97.06±0.1이었고, 나머지 성분이 0.04±0.01이었다. 틸리파아와 같은 민물 어종인 잉어의 비늘을 대상으로 성분 분석을 한 결과 비늘 100g 중 조단백질이 잉어는 78.88g임을 감안하면, 상기 결과는 같은 민물 어종인 틸라피아 비늘의 단백질 함량이 매우 높다는 것을 알 수 있다. 이것으로부터 틸라피아 비늘이 함유한 단백질의 높은 함량은 단백질 원료 산업에서 유용하게 이용될 수 있음을 확인할 수 있다.As shown in Table 1, the moisture content was 2.6 ± 0.01, the ash content was 0.3 ± 0.01, the crude protein content was 97.06 ± 0.1, and the remaining components were 0.04 ± 0.01. As a result of component analysis of carp scales of freshwater fish such as tilipea, considering that crude protein of carp is 78.88g among 100g of scales, the result shows that the protein content of tilapia scales of the same freshwater fish is very high. From this, it can be seen that the high content of protein contained in tilapia scales can be usefully used in the protein raw material industry.
3. 틸라피아 비늘로부터 효소적 가수분해물의 제조3. Preparation of Enzymatic Hydrolysates from Tilapia Scales
건조된 틸라피아 비늘을 표 2에 제시된 것과 같이 5종의 단백질 가수분해효소를 이용하여 그 효소에 해당하는 적정 조건하에서 틸라피아 비늘의 효소적 가수분해물을 다음의 두가지 방법으로 제조하였다.As shown in Table 2, dried tilapia scales were prepared by enzymatic hydrolysates of tilapia scales under the appropriate conditions corresponding to the enzymes by using five proteolytic enzymes in the following two methods.
표 2
효소 pH 온도(℃) 기원
α-키모트립신(α-chymotrypsin) 7.8 25 Bovine Pancreas
알칼라아제(alcalase) 8.0 50 Bacillus licheniformis
코지자임(kojizyme) 6.0 40 Bacillus sp.
프로타멕스(protamex) 6.0 40 A. oryzae
트립신(trypsin) 7.6 25 Procine Pancreas
TABLE 2
enzyme pH Temperature (℃) origin
α-chymotrypsin 7.8 25 Bovine pancreas
Alcalase 8.0 50 Bacillus licheniformis
Kojizyme 6.0 40 Bacillus sp.
Protamex 6.0 40 A. oryzae
Trypsin 7.6 25 Procine pancreas
첫 번째 방법으로는, 틸라피아 비늘을 열수 추출 없이 곧바로 효소를 이용하여 가수분해하였다. 즉, 틸라피아 비늘 10g을 증류수 100ml와 섞은 후, 각각의 효소를 첨가하여 각 효소별 최적 pH와 온도에서 시간 경과(3, 6, 12, 18, 24시간)에 따라 가수분해 하였다.In the first method, tilapia scales were hydrolyzed directly using enzymes without hot water extraction. That is, 10 g of tilapia scales were mixed with 100 ml of distilled water, and then, each enzyme was added and hydrolyzed over time (3, 6, 12, 18, 24 hours) at the optimum pH and temperature for each enzyme.
두 번째 방법으로는, 틸라피아 비늘 10g을 증류수 100ml와 혼합한 후, 100℃에서 3시간 동안 열수 추출한 후, 각각의 효소를 첨가하여 각 효소별 최적 pH와 온도에서 시간 경과(3, 6, 12, 18, 24시간)에 따라 가수분해하였다.In the second method, 10 g of tilapia scales were mixed with 100 ml of distilled water, followed by hot water extraction at 100 ° C. for 3 hours, and then the addition of the respective enzymes, followed by time lapse (3, 6, 12, 18, 24 hours).
위에서 설명된 각각의 방법에 따라 제조된 가수분해물을 100℃에서 10분 동안 끓여 효소 반응을 정지시키고, pH를 중성으로 맞춘 후 원심분리(3500rpm, 10분)와 감압여과로 상층액을 분리하였다. 분리된 상층액을 동결건조하여 시료로 이용하였다.The hydrolyzate prepared according to each method described above was boiled at 100 ° C. for 10 minutes to stop the enzyme reaction, and after adjusting the pH to neutral, the supernatant was separated by centrifugation (3500 rpm, 10 minutes) and vacuum filtration. The separated supernatant was lyophilized and used as a sample.
4. 틸라피아 비늘 유래 효소적 가수분해물의 가수분해도 측정4. Determination of the degree of hydrolysis of enzymatic hydrolysates derived from tilapia scales
틸라피아 비늘 유래 효소적 가수분해물의 가수분해도를 TCA(trichloroacetic acid)법으로 측정하였다. 즉, 반응이 종료된 반응 혼합물을 원심분리(12000rpm, 15분)하여 상층액으로부터 2ml를 취하고, 여기에 20% TCA를 동량 첨가하여 원심분리(3500rpm, 10분)한 다음, 상층액의 일정량을 취하여 Lowry법으로 10% TCA 가용성 질소량을 측정하여 다음의 식으로부터 가수분해도를 계산하였다.The degree of hydrolysis of enzymatic hydrolysates derived from tilapia scales was measured by TCA (trichloroacetic acid) method. In other words, the reaction mixture after the reaction was centrifuged (12000 rpm, 15 minutes) to take 2 ml from the supernatant, 20% TCA was added thereto in the same amount, centrifuged (3500 rpm, 10 minutes), and then a predetermined amount of the supernatant was removed. 10% TCA soluble nitrogen was measured by Lowry method, and the degree of hydrolysis was calculated from the following equation.
가수분해도(%)=(10% TCA 가용성 질소량/총질소량)×100Degree of Hydrolysis (%) = (10% TCA Soluble Nitrogen / Total Nitrogen) × 100
틸라피아 비늘의 열수추출 과정 없이 효소적 가수분해만을 수행한 경우, 3시간부터 12시간까지는 시간 의존적으로 모든 5종의 효소적 가수분해물의 가수분해도가 증가한 것을 확인하였고, 12시간 이후에는 거의 유사하거나 다소 감소하는 경향을 보였다(도 2).When only enzymatic hydrolysis was performed without hydrothermal extraction of tilapia scales, it was confirmed that the hydrolysis degree of all five enzymatic hydrolysates was increased in a time-dependent manner from 3 hours to 12 hours. It tended to decrease (FIG. 2).
한편, 틸라피아 비늘의 열수 처리 후, 효소적 가수분해로 제조된 가수분해물들은 효소만을 이용하여 제조한 가수분해물들에 비해 상당히 높은 가수분해도를 보였다. 또한, 열수 처리 후, 효소적 가수분해를 시도하였을 때, 그 가수분해도는 α-키모트립신을 제외하고 6시간까지 급격히 증가하다가 그 이후까지 가수분해도는 일정하게 유지되었다. 그러나, α-키모트립신에 의해 제조된 가수분해물은 12시간까지 지속적으로 가수분해도의 증가를 보였으며, 12시간 가수분해에서 약 55%의 높은 가수분해도를 보였다(도 3). 따라서, 틸라피아 비늘의 경우 열수 처리 후, α-키모트립신 효소를 처리하는 것이 가장 효율적으로 가수분해되었다는 것을 알 수 있다.On the other hand, after hydrothermal treatment of tilapia scales, hydrolyzates prepared by enzymatic hydrolysis showed a significantly higher degree of hydrolysis than those produced by enzymes alone. In addition, when enzymatic hydrolysis was attempted after hydrothermal treatment, the degree of hydrolysis rapidly increased up to 6 hours except for α-chymotrypsin, and the degree of hydrolysis remained constant thereafter. However, hydrolyzate prepared by α-chymotrypsin showed a continuous increase in degree of hydrolysis up to 12 hours, and showed a high degree of hydrolysis of about 55% at 12 hours of hydrolysis (FIG. 3). Thus, it can be seen that for the tilapia scales, treatment with α-chymotrypsin enzyme after hydrothermal treatment was most efficiently hydrolyzed.
5. 틸라피아 비늘 유래 효소적 가수분해물의 최적 가수분해 조건5. Optimal Hydrolysis Conditions of Enzymatic Hydrolysates from Tilapia Scales
효소 가수분해물의 최적 가수분해 조건을 결정하기 위하여, α-키모트립신 효소적 가수분해물의 기질 대 효소비와 기질 농도에 따라 가수분해를 수행하였다.To determine the optimal hydrolysis conditions of the enzymatic hydrolyzate, hydrolysis was performed according to the substrate-to-enzyme ratio and substrate concentration of the α-chymotrypsin enzymatic hydrolyzate.
기질 대 효소비는 10, 20, 50, 100, 200, 500(중량/중량)이었고, 기질인 틸라피아 비늘의 효소적 가수분해물 농도는 1%, 3%, 5%, 10%, 20%이었다.Substrate-to-enzyme ratios were 10, 20, 50, 100, 200, 500 (weight / weight) and enzymatic hydrolyzate concentrations of the substrate, tilapia scales, were 1%, 3%, 5%, 10%, and 20%.
가수분해는 위에서 제시된 방법과 동일하게 수행하였고, 모든 가수분해 조건의 검토를 위하여 가수분해물의 가수분해도를 측정하였다.The hydrolysis was carried out in the same manner as the method presented above, and the degree of hydrolysis of the hydrolyzate was measured for the examination of all hydrolysis conditions.
12시간째 α-키모트립신 가수분해물을 가지고 기질 대 효소비를 상기와 같이 하여 가수분해도를 측정한 결과, 도 4에 나타난 바와 같이 틸라피아 비늘인 기질 대 효소의 비가 증가할수록, 즉 효소의 농도가 감소할수록 가수분해도는 감소하였다. 또한, 틸라피아 비늘 대 효소의 비율이 10부터 200까지 증가하면서 가수분해도가 약 65%에서 약 45%까지 급격히 감소하였고, 200부터 500까지는 거의 유사한 가수분해도를 나타내었다. 이러한 결과로부터 기질 대 효소비가 100인 경우 가수분해도에 대한 경제적인 효율성을 보인다는 것을 확인할 수 있었다.As a result of measuring the degree of hydrolysis with the α-chymotrypsin hydrolyzate at 12 hours as described above, as shown in FIG. 4, as the ratio of the substrate to the enzyme of tilapia scales increased, that is, the concentration of the enzyme decreased. As the degree of hydrolysis decreased. In addition, as the ratio of tilapia scales to enzymes increased from 10 to 200, the degree of hydrolysis rapidly decreased from about 65% to about 45%, and from 200 to 500, the degree of hydrolysis was almost similar. From these results, it can be seen that when the substrate-to-enzyme ratio of 100 shows economic efficiency on the degree of hydrolysis.
다음으로, 틸라피아 비늘의 α-키모트립신 가수분해물을 100(wt/wt)에서 기질 농도별로 측정한 결과는 도 5에 나타낸 바와 같이, 기질의 농도가 낮을수록 가수분해도가 다소 증가하는 것을 확인할 수 있었다.Next, as a result of measuring the α-chymotrypsin hydrolyzate of the tilapia scales at the substrate concentration at 100 (wt / wt), as shown in FIG. 5, the lower the concentration of the substrate, the higher the degree of hydrolysis was confirmed. .
6. 틸라피아 비늘 유래 효소적 가수분해물의 여과6. Filtration of Enzymatic Hydrolysates from Tilapia Scales
틸라피아 비늘의 α-키모트립신 가수분해물은 활성탄 여과막을 통하여 1차로 여과하고, 다음으로 0.45μm 직경의 여과막으로 2차 여과하였다. 다음으로, 이온교환수지막을 통하여 3차로 여과하여 최종적인 여과물을 얻었다.The α-chymotrypsin hydrolyzate of the tilapia scales was first filtered through an activated carbon filtration membrane, and then secondarily filtered through a 0.45 μm diameter filtration membrane. Next, the filtrate was filtered through an ion exchange resin membrane in 3rd order to obtain a final filtrate.
7. 틸라피아 비늘 유래 효소적 가수분해물로부터 분자량별 분획물의 제조7. Preparation of molecular weight fractions from enzymatic hydrolysates derived from tilapia scales
분자량별 분획물을 제조하기 위하여, α-키모트립신으로 처리된 틸라피아 효소적 가수분해물의 여과물은 5kDa, 10kDa, 30kDa의 막을 사용하여 한외여과막 분리 시스템(ultrafiltration membrane)을 이용하여 5kDa 이하, 10kDa 이하, 30kDa 이하 분획물들을 각각 제조하였다.In order to prepare molecular weight fractions, the filtrate of tilapia enzymatic hydrolyzate treated with α-chymotrypsin was 5 kDa or less, 10 kDa or less, using an ultrafiltration membrane using 5 kDa, 10 kDa, 30 kDa membranes. Each fraction below 30 kDa was prepared.
8. 항산화 활성 측정8. Determination of Antioxidant Activity
DPPH는 free radical의 안정된 모델로 반응 중 DPPH의 감소는 free radical의 소거반응이 진행됨을 알 수 있고, 지질과산화의 초기반응의 억제정도를 예측할 수 있다. 유해산소라 불려지는 활성산소는 세포 생체막의 구성성분인 불포화 지방산을 공격하여 지질과산화 반응을 일으켜 체내 과산화 지질을 축적함으로 인해 생체 기능이 저하되고 동시에 노화 및 성인병 질환을 유발하는 것으로 알려져 있으며 다양한 종류의 식물성분 및 추출물에 의한 항산화 작용이 보고되고 있다. 또한, H2O2 역시 대표적인 활성산소로 H2O2의 감소정도로 항산화 반응의 정도를 측정할 수 있다.DPPH is a stable model of free radicals. It can be seen that DPPH reduction during the reaction proceeds to scavenging free radicals and predicts the inhibition of the initial reaction of lipid peroxidation. Active oxygen, called harmful oxygen, is known to attack unsaturated fatty acids, which are components of cell membranes, to induce lipid peroxidation reactions and to accumulate lipid peroxides in the body, resulting in deterioration of biological function and aging and adult diseases. Antioxidant activity by plant components and extracts has been reported. In addition, H 2 O 2 is also a representative active oxygen can be measured the degree of antioxidant reaction to the extent of reduction of H 2 O 2 .
도 6 및 도 7에 나타낸 바와 같이, 본 발명의 틸라피아 비늘 효소적 가수분해물 및 각 한외여과 분획물들은 우수한 DPPH radical 소거 기능이 있음을 확인할 수 있다.As shown in Figures 6 and 7, the tilapia scale enzymatic hydrolyzate and each ultrafiltration fraction of the present invention can be confirmed that the excellent DPPH radical scavenging function.
9. 주름 개선 효과 9. Wrinkle improvement effect
피부의 진피 조직 속에는 콜라겐과 엘라스틴이 그물망 구조를 형성하면서 피부의 탄력성을 유지시켜 주는데 나이, 자외선과 같은 내외적 스트레스로 인하여 탄력성, 윤택성이 감소하고, 과다 발현된 엘라스티나아제에 의하여 엘라스틴의 그물망 구조가 깨지게 되면 피부가 처지고 주름이 생기므로 피부노화가 발생하게 된다. 따라서, 피부노화의 주원인 중 하나인 엘라스틴의 분해효소인 엘라스티나아제의 활성을 저해시킴으로써 피부 노화를 억제할 수 있다.In the dermal tissue of the skin, collagen and elastin form the network structure and maintain the elasticity of the skin.The elasticity and the luster decrease due to internal and external stress such as age and ultraviolet rays, and the elastin mesh is caused by the overexpressed elastinase. If the structure is broken, the skin sags and wrinkles are generated, resulting in skin aging. Therefore, skin aging can be suppressed by inhibiting the activity of elastinase, which is an enzyme of elastin, one of the main causes of skin aging.
틸라피아 비늘젤라틴 효소 가수분해물 및 4종의 한외 여과 분획물의 주름개선효과를 시험하기 위하여 Cannell 등의 방법을 이용하여 elastinase의 저해활성을 측정하였다. Elastinase 저해 활성 측정은 기질로서 elastinase substrate VIII를 사용하여 실온에서 15분간 반응시켜 p-nitoanilide의 생성량을 측정하였다. 0.2M tris-HCl(pH 8.0) buffer로 희석한 각 시험용액 160μl와 5mM elastinase substrate VIII(CALBIOCHEM) 용액 20μl 그리고 10μl/ml elastinase(sigma) 효소 20μl를 순서대로 넣은 후 25℃에서 15분 동안 반응시킨 후 ELISA reader(TECAN, AT/sunrise R/C, Switzerland)를 이용하여 410nm에서 흡광도를 측정하였다.In order to test the antiwrinkle effect of tilapia scale gelatin enzyme hydrolyzate and four ultrafiltration fractions, the inhibitory activity of elastinase was measured using Cannell et al. Elastinase inhibitory activity was measured by elastinase substrate VIII as a substrate for 15 minutes at room temperature to determine the amount of p-nitoanilide produced. 160 μl of each test solution diluted with 0.2 M tris-HCl (pH 8.0) buffer, 20 μl of 5 mM elastinase substrate VIII (CALBIOCHEM) solution and 20 μl of 10 μl / ml elastinase (sigma) enzyme were added in this order and reacted at 25 ° C. for 15 minutes. After absorbance was measured at 410nm using an ELISA reader (TECAN, AT / sunrise R / C, Switzerland).
도 8에 나타난 바와 같이, 본 발명의 틸라피아 비늘 효소적 가수분해물 및 각 한외여과 분획물들은 우수한 엘라스티나아제 저해 활성을 나타냄을 확인할 수 있다.As shown in Figure 8, the tilapia scale enzymatic hydrolyzate and each ultrafiltration fraction of the present invention can be seen to exhibit excellent elastinase inhibitory activity.
10. 미백 효과10. Whitening effect
틸라피아 비늘 알칼라아제 가수분해물 및 한외여과 분획물의 미백효과를 시험하기 위하여, Fuller 등의 방법을 이용하여 tyrosinase의 저해활성을 측정하였다. 0.1M 인산염완충액(pH 6.5) 220μl와 시료액 20μl 그리고 tyrosinase(sigma)(1500U/ml~2000U/ml)액 20μl를 순서대로 넣는다. 이 용액에 1.5mM trysine(sigma) 액 40μl를 넣고 37℃에서 10~15분 동안 반응시킨 후 ELISA reader(TECAN, AT/sunrise R/C, Switzerland)를 이용하여 490nm에서 흡광도를 측정하였다. 공시료액으로 시료액 대신 0.1M 인산염완충액(pH 6.5)을 사용하였다. In order to test the whitening effect of tilapia scale alkalase hydrolysates and ultrafiltration fractions, the inhibitory activity of tyrosinase was measured using the method of Fuller. Add 220 μl of 0.1M phosphate buffer (pH 6.5), 20 μl of sample solution, and 20 μl of tyrosinase (sigma) solution (1500 U / ml ~ 2000 U / ml). 40μl of 1.5mM trysine (sigma) solution was added to the solution and reacted at 37 ° C. for 10-15 minutes, and the absorbance was measured at 490 nm using an ELISA reader (TECAN, AT / sunrise R / C, Switzerland). 0.1 M phosphate buffer (pH 6.5) was used instead of the sample solution as the blank sample solution.
Figure PCTKR2013010020-appb-I000001
Figure PCTKR2013010020-appb-I000001
멜라닌 합성은 아미노산의 하나인 tyrosine을 기질로 하여 tyrosinase에 의해 3,4-dihydroxyphenylalanin(DOPA)와 DOPA quinone 이후의 반응은 크게 적갈색이나 황색을 결정하는 pheomelanin과 흑갈색에서 갈색을 결정하는 eumelanin 생성의 2가지로 나뉘어지며, 멜라닌 생성의 주요 효소인 tyrosinase의 활성을 저해함으로써 멜라닌 생성을 억제시켜 미백효과를 기대할 수 있다.Melanin synthesis is based on tyrosine, one of the amino acids, and the reaction after 3,4-dihydroxyphenylalanin (DOPA) and DOPA quinone by tyrosinase is largely pheomelanin, which determines reddish brown or yellow color, and eumelanin, which determines brown to brown color. It is divided into, and whitening effect can be expected by inhibiting melanin production by inhibiting the activity of tyrosinase, a major enzyme of melanin production.
이에 본 실험에서는 틸라피아 비늘 유래 젤라틴 가수분해물 및 이로부터 얻은 4종의 한외 여과 분획물의 tyrosinase 저해활성을 측정하였다. 도 9에 나타난 바와 같이, 본 발명의 틸라피아 비늘 효소적 가수분해물 및 각 한외여과 분획물들은 우수한 티로시나아제 저해활성을 나타냄을 확인할 수 있다.In this experiment, the tyrosinase inhibitory activity of the gelatin hydrolyzate derived from tilapia scales and four ultrafiltration fractions obtained therefrom was measured. As shown in Figure 9, the tilapia scale enzymatic hydrolyzate and each ultrafiltration fraction of the present invention can be seen to exhibit excellent tyrosinase inhibitory activity.
11. 틸라피아 비늘 가수분해물의 한외 여과 분획물(단백질펩타이드)의 독성검사 11. Toxicity of Ultrafiltration Fractions (Protein Peptides) from Tilapia Scale Hydrolysates
틸라피아 비늘 단백질 펩타이드의 독성검사를 바이오톡스텍 전문기관에 의뢰하였으며, 자세한 결과는 다음과 같다.Toxicity testing of tilapia scale protein peptides was commissioned by a Biotoxtec specialized institution. Detailed results are as follows.
11-1. 틸라피아 비늘 효소가수분해물의 렛드를 이용한 단회 경구투여 독성시 11-1. Single Oral Dose Toxicity Test Using a Red Tilapia Scale Enzyme Hydrolyzate
시험목적 : 암수 Sprague-Dawley 랫드를 이용하여 시험물질인 틸라피아비늘 효소 가수분해물을 단회 경구투여시 나타나는 독성반응을 관찰하고, 개략의 치사량을 구하기 위하여 실시하였다.OBJECTIVES: To investigate the toxic response of a single oral dose of Tilapia scale enzyme hydrolyzate as a test substance in male and female Sprague-Dawley rats.
요약 및 결론 : 군구성은 시험물질 2,000 mg/kg의 용량 및 대조군 (주사용수)의 2군으로 하고, 암수 각각 5 마리씩 단회 경구투여 하였다. 투여 후 14일 동안, 일반증상의 관찰 및 체중측정을 실시하였고, 관찰기간 종료 시에 안락사시켜 부검하였다. 암수 2,000 mg/kg 투여군에서 사망례는 관찰되지 않았다. 또한, 일반증상, 체중 및 부검에서 시험물질 투여에 의한 영향은 인정되지 않았다. 본 시험의 조건 하에서 틸라피아비늘 효소 가수분해물을 랫드에 단회 경구투여한 결과, 개략의 치사량은 암수 각2,000 mg/kg을 상회하는 것으로 판단된다.Summary and Conclusion: The group consisted of 2,000 mg / kg of test substance and 2 groups of control group (injection water), and five male and female mice were orally administered once. For 14 days after administration, general symptoms and body weights were observed, and euthanized by euthanasia at the end of the observation period. No deaths were observed in the 2,000 mg / kg male and female groups. In addition, the effects of test substance administration on general symptoms, body weight and necropsy were not recognized. As a result of a single oral administration of tilapia scale enzyme hydrolyzate to rats under the conditions of this test, the approximate lethal dose is estimated to be greater than 2,000 mg / kg of male and female.
11-2. 틸라피아 비늘 효소가수분해물의 토끼를 이용한 피부자극시험11-2. Skin irritation test using rabbit of Tilapia scale enzyme hydrolyzate
시험목적 : 시험물질 틸라피아비늘 효소 가수분해물을 토끼의 피부에 1회 처치한 후, 피부자극성의 유무 및 그 정도를 평가하기 위해 실시하였다.Purpose: To test the test substance tilapia scale enzyme hydrolyzate once in the skin of rabbits and to evaluate the presence and extent of skin irritation.
요약 및 결론 : 시험물질 틸라피아비늘 효소 가수분해물의 피부자극시험을 16주령의 수컷 NZW 토끼 3마리를 사용해서 검토하였다. 토끼의 등부위에 좌우 각 2부위, 합 4부위의 투여부위를 설정하고, 그 중 2부위를 비찰과부위, 그 외 2부위를 찰과부위로 하였다. 시험물질원말 0.5 g을 각 1개의 비찰과 및 찰과부위의 투여부위에 적용하여 24시간 폐색첩포하였다. 투여 후 24, 48 및 72시간에 Draize의 피부반응 평가표에 따라서 피부반응을 평가하고, 투여 후 24 및 72시간에 대한 1차피부자극지수 (Primary Skin Irritation Index, P.I.I.)를 구하여 피부자극성을 판정하였다. 시험물질투여부위및 무처치대조부위의 비찰과 및 찰과부위에서 투여 후 24, 48 및 72시간에 홍반 및 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 시험물질의 1차피부자극지수 (P.I.I.)는 0이었다. 관찰기간 중, 일반증상 및 체중에 대해서 이상은 확인되지 않았다. 이상의 결과로부터, 본시험 조건하에서 시험물질 틸라피아비늘 효소 가수분해물은 토끼의 피부에 대해서 자극이 없는 것으로 판단된다.SUMMARY AND CONCLUSIONS: The skin irritation test of test substance tilapia scale enzyme hydrolyzate was examined using three 16-week-old male NZW rabbits. The administration sites of the left and right each 2 sites and the sum 4 sites were set to the back of the rabbit, and 2 of them were irradiated and the other 2 were used as abrasion sites. 0.5 g of the test substance raw material was applied to each non-abrasive and abrasion site for 24 hours to blockage patch. The skin response was assessed according to Draize's Skin Response Evaluation Table at 24, 48 and 72 hours after dosing, and the primary skin irritation index (PII) was determined for 24 and 72 hours after dosing to determine skin irritation. . Skin reactions such as erythema and edema were not observed in all animals at 24, 48 and 72 hours post-administration at non-treated and untreated control sites. The primary skin irritation index (P.I.I.) of the test substance was zero. During the observation period, no abnormalities were observed for general symptoms and body weight. From the above results, it is judged that the test substance tilapia scale enzyme hydrolyzate is not irritating to the skin of the rabbit under the present test conditions.
11-3. 틸라피아 비늘 효소가수분해물의 토끼를 이용한 안점막자극시험11-3. Ocular Membrane Stimulation Test Using Rabbits of Tilapia Scale Enzyme Hydrolysates
시험목적 : 시험물질 틸라피아비늘 효소 가수분해물을 토끼의 안점막에 1회 처치한 후, 안자극성의 유무 및 그 정도를 평가하기 위해 실시하였다.Purpose: To test the test substance tilapia scale enzyme hydrolyzate once in rabbit ocular mucosa and to evaluate the presence and degree of eye irritation.
요약 및 결론 : 시험물질 틸라피아비늘 효소 가수분해물의 안자극시험을 16주령의 수컷 NZW 토끼 6마리를 사용해서 검토하였다. 비세안군은 토끼 3마리의 우안 결막낭 내에 시험물질원말 0.1 g을 투여하고, 투여 후 1, 24, 48 및 72시간에 각막, 홍채 및 결막등의 안구병변을 관찰하였다. 세안군은 추가로 3마리를 사용해서 비세안군과 동일하게 투여하고, 투여 30초 후에 세척한 후 세안효과를 확인하였다. Draize의 안구병변의 등급에 따라서 시험물질의 안점막자극을 평가하고, Guillot의 안점막자극 평가표를 참조해서 안점막자극의 정도를 분류하였다. 비세안군에서는, 시험물질 투여 후 1시간 이후에 결막발적 (평점 1) 및 결막부종 (평점 1)이 관찰되었으나, 투여 후 48시간에 모두 소실되었다. 비세안군의 I.A.O.I. (Index of Acute Ocular Irritation)는 4.0으로 최종평가는 무자극물로 분류되었다. 세안군에서는, 시험물질 투여 후 1시간에 결막발적 (평점 1) 및 결막부종 (평점 1)이 관찰되었으나, 투여후 24시간에 모두 소실되었다. 세안군의 I.A.O.I.는 4.0으로, 비세안군과 비교해서 자극정도는 차이가 없지만, 안자극성의 소실시간에서 차이가 있기 때문에 세안효과가 확인되었다. 관찰기간 중, 각군의 일반증상 및 체중에 대해서 이상은 확인되지 않았다. 이상의 결과로부터, 본시험 조건하에서 시험물질 틸라피아비늘 효소 가수분해물은 토끼의 안점막에 대해서 무자극물로 판단된다.SUMMARY AND CONCLUSIONS: Eye irritation testing of test substance tilapia scale enzyme hydrolyzate was reviewed using six 16-week-old male NZW rabbits. In the non-eye group, 0.1 g of test substance was injected into three rabbits' right eye conjunctival sac, and eye lesions such as cornea, iris and conjunctiva were observed at 1, 24, 48 and 72 hours after administration. The face wash group was additionally administered in the same manner as the non-wash face group using three animals, and after washing for 30 seconds after administration, the face wash effect was confirmed. The eye irritation of the test substance was evaluated according to the grade of the eye lesion of Draize, and the degree of eye irritation was classified by referring to Guillot's eye irritation evaluation table. In the non-eye group, conjunctival redness (score 1) and conjunctival edema (score 1) were observed 1 hour after administration of the test substance, but all disappeared at 48 hours after administration. I.A.O.I. The Index of Acute Ocular Irritation was 4.0 and the final assessment was classified as non-irritant. In the face-wash group, conjunctival redness (score 1) and conjunctival edema (score 1) were observed 1 hour after administration of the test substance, but all disappeared 24 hours after administration. The I.A.O.I. of the cleansing group was 4.0, and there was no difference in the stimulus degree compared to the non-cleansing group, but the cleansing effect was confirmed because there was a difference in the disappearance time of eye irritation. During the observation period, no abnormalities were observed for general symptoms and body weight of each group. From the above results, the test substance tilapia scale enzyme hydrolyzate under this test condition is judged to be non-irritant to the ocular mucosa of rabbits.
11-4. 틸라피아비늘 효소 가수분해물의 기니픽을 이용한 피부감작성시험 (Maximization법) 11-4. Skin sensitization test using guinea pigs of Tilapia scale enzyme hydrolyzate (Maximization method)
시험목적 : 시험물질 틸라피아비늘 효소 가수분해물의 안전성 시험의 일환으로, 기니픽을 이용한 피부감작성시험 (Maximization법)을 실시하여 인체 피부에 대한 알레르기 유발가능성을 검토하였다.Objective: As part of the safety test of the test substance tilapia scale enzyme hydrolyzate, a skin sensitization test (Maximization method) using guinea pigs was conducted to examine the possibility of allergic to human skin.
요약 및 결론 : 시험물질 틸라피아비늘 효소 가수분해물의 피부감작성시험을 Hartley계 기니픽을 사용하여 Maximization법으로 검토하였다. 시험군은 시험물질군 (5마리), 음성대조군 (5마리) 및 양성대조군 (5마리)의 합 3군으로 하였다. 또한, 예비시험의 경피투여 부위에서 홍반, 부종등의 피부반응이 확인되지 않았기 때문에, 2차감작 24시간 전에 양성대조군을 제외한 각 군의 감작부위에 10% sodium dodecyl sulfate (SDS)를 도포하였다. 시험물질군은 50% 시험물질을 피내투여해서 1차감작하고, 100% 시험물질을 48시간 폐색첩포하여 2차감작하였다. 100% 시험물질 및 주사용수로 24시간 폐색첩포하여 야기한 결과, 야기 패취제거 후 24 및 48시간에 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 음성대조군은 주사용수로 1차 및 2차감작하고, 100% 시험물질 및 주사용수로 야기한 결과, 야기 패취제거 후 24 및 48시간에 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 양성대조군은 0.1 및 1.0% 1-Chloro-2,4-dinitrobenzene (CDNB)으로 각각 1차 및 2차감작하고, 0.1% CDNB 및 olive oil로 야기한 결과, 야기패취 제거 후 24 및 48시간에 0.1% CDNB의 야기부위에서 평점 3의 강한홍반 및 부종이 모든 동물에서 관찰되었다. Olive oil의 야기부위에서는 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 관찰기간 중, 각 군의 모든 동물의 일반증상 및 체중에 대해서 이상은 확인되지 않았다. 이상의 결과로부터, 본시험 조건하에서 시험물질 틸라피아비늘 효소 가수분해물은 피부감작성이 없는 물질로 판단된다.SUMMARY AND CONCLUSIONS: The skin sensitization test of test substance tilapia scale enzyme hydrolyzate was reviewed by the Maximization method using Hartley guinea pig. The test group consisted of three groups: test substance group (5), negative control group (5) and positive control group (5). In addition, 10% sodium dodecyl sulfate (SDS) was applied to the sensitized area of each group except the positive control group 24 hours before the second sensitization because no skin reactions such as erythema and edema were observed at the percutaneous administration site of the preliminary test. The test substance group was firstly sensitized by intradermal administration of 50% test substance, and secondly sensitized by 100% test substance for 48 hours. As a result of 24-hour obstruction with 100% test substance and water for injection, skin reactions such as erythema and edema were not observed in all animals 24 and 48 hours after removal of the induced patch. Negative controls were primary and secondary sensitized with water for injection, and as a result of 100% test substance and water for injection, skin reactions such as erythema and edema were not observed in all animals 24 and 48 hours after the removal of the induced patch. Positive controls were first and second sensitization with 0.1 and 1.0% 1-Chloro-2,4-dinitrobenzene (CDNB), respectively, and caused by 0.1% CDNB and olive oil, resulting in 0.1% at 24 and 48 hours after removal of the Yagi patch. Grade 3 strong erythema and edema in the causal region of CDNB were observed in all animals. Skin reactions such as erythema and edema were not observed in all animals. During the observation period, no abnormalities were observed for the general symptoms and body weight of all animals in each group. From the above results, the test substance tilapia scale enzyme hydrolyzate under this test condition is judged to be a substance without skin sensitization.
11-5. 틸라피아비늘 효소 가수분해물의 기니픽을 이용한 광독성시험11-5. Phototoxicity Test Using Guinea Pigs of Tilapia Scale Enzyme Hydrolysate
시험목적 : 시험물질 틸라피아비늘 효소 가수분해물의 안전성 시험의 일환으로, 기니픽의 피부를 이용해서 광독성 유발 가능성을 검토하였다.Objective: As part of the safety test of the test substance tilapia scale enzyme hydrolyzate, the possibility of phototoxicity was examined using skin of guinea pigs.
요약 및 결론 : 시험물질 틸라피아비늘 효소 가수분해물의 피부에 대한 광독성 유무 및 그 정도를 Hartley계 기니픽을 이용해서 검토하였다. 시험군은 시험물질군 (5마리), 음성대조군 (5마리) 및 양성대조군 (5마리)의 합 3군으로 하였다. 시험물질군, 음성대조군 및 양성대조군의 제모한 기니픽의 등부 피부에 좌우 각 1부위, 합 2부위의 22 cm의 투여부위를 설정하였다. 시험물질군에는 90% 시험물질을, 음성대조군에는 주사용수를, 양성대조군에는 0.1% 8-Methoxypsoralen (8-MOP)을 0.05 mL씩 각 투여부위에 개방도포하였다. 도포 약 30분 후 좌측을 광조사부위, 우측을 비광조사부위로해서 최종에너지가 약 10 J/cm2이 되도록 UV-A를 조사하였다. 광조사 후 24, 48 및 72 시간에 피부반응을 평가하고, 광독성 유무를 판정하였다. 시험물질군의90% 시험물질의 투여부위에서 광조사 후 24, 48 및 72 시간에, 광조사 유무에 관계없이 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 음성대조군의 주사용수의 투여부위에서 모든 관찰시간에, 광조사 유무에 관계없이 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 양성대조군의0.1% 8-MOP의 투여부위에서는 모든 관찰시간에, 광조사부위에서 홍반 (평점 3) 및 부종 (평점 4)이 모든 동물에서 관찰되었으나, 비광조사부위에서는 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 관찰기간 중, 각 군의 일반증상 및 체중에 대해서 이상은 확인되지 않았다. 이상의 결과로부터, 본시험 조건하에서 시험물질 틸라피아비늘 효소 가수분해물은 광독성이 없는 물질로 판단된다.SUMMARY AND CONCLUSIONS: The presence and extent of phototoxicity of the test substance tilapia scale enzyme hydrolyzate to the skin were examined using Hartley guinea pigs. The test group consisted of three groups: test substance group (5), negative control group (5) and positive control group (5). 22 cm of administration sites were set on the right and left sides of the guinea-pig skin of the test substance group, the negative control group, and the positive control group. 90% test substance was applied to the test substance group, water for injection to the negative control group, and 0.1% 8-Methoxypsoralen (8-MOP) to the positive control group was applied to each administration site. About 30 minutes after application, UV-A was irradiated so that the final energy was about 10 J / cm 2 with the light irradiation site on the left side and the non-light irradiation site on the right side. Skin reactions were evaluated 24, 48 and 72 hours after light irradiation, and the presence or absence of phototoxicity was determined. Skin reactions such as erythema and edema were not observed in all animals at 24, 48 and 72 hours after irradiation at 90% of the test substance dose. At all observation times at the injection site of the negative control group, no skin reactions such as erythema and edema were observed in all animals. At the time of observation, 0.1% 8-MOP of the positive control group showed erythema (score 3) and edema (score 4) at all the irradiation sites, but skin reactions such as erythema and swelling at the non-irradiation site were observed. Was not observed in all animals. During the observation period, no abnormalities were identified for general symptoms and body weight of each group. From the above results, the test substance tilapia scale enzyme hydrolyzate is judged to be non-phototoxic under the present test conditions.
11-6. 틸라피아비늘 효소 가수분해물의 기니픽을 이용한 광감작성시험 (Adjuvant & Strip법) 11-6. Photosensitization Test Using Guinea Pigs of Tilapia Scale Enzyme Hydrolysates (Adjuvant & Strip Method)
시험목적 : 시험물질 틸라피아비늘 효소 가수분해물의 피부에 대한 안전성 시험으로, 기니픽을 이용한 Adjuvant & Strip법을 실시하여 광감작성의 유발 가능성을 검토하였다.Purpose: To test the safety of the test substance tilapia scale enzyme hydrolyzate on the skin. Adjuvant & Strip method using guinea pigs was performed to investigate the possibility of photosensitization.
요약 및 결론 : 시험물질 틸라피아비늘 효소 가수분해물의 광감작성을 Hartley계, 수컷 기니픽을 이용해서 Adjuvant & Strip법으로 검토하였다. 군구성은 시험물질군 (5마리), 음성대조군 (5마리) 및 양성대조군 (5마리)의 합 3군으로 하였다. 투여 0일에 감작부위 네 모서리에 주사용수-FCA 유화액을 피내주사한 후, 감작부위를 stripping 하였다. 시험물질군, 음성대조군 및 양성대조군의 감작부위에 각각 90% 시험물질, 주사용수 및 1.0% chlorpromazine (CP)을 0.1 mL씩 개방도포한 후, UV-A를 조사하였다. Stripping, 투여물질의 개방도포 및 UV-A 조사를 1일 1회, 5일간 연속해서 실시하였다. 야기는 투여 21일에 시험물질군 및 음성대조군에는 90% 시험물질 및 주사용수를, 양성대조군에는 0.1% CP 및 ethanol을 야기부위에 개방도포한 후, UV-A를 조사하여 야기하였다. 야기 광조사 후 24 및 48시간에 피부반응을 평가하였다. 시험물질군 및 음성대조군은 야기 광조사 후 24 및 48시간에, 90% 시험물질 및 주사용수의 야기부위에서 광조사 유무에관계없이 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 양성대조군은 모든 관찰시간에, 0.1% CP의 광조사부위에서 평점 3의 홍반 및 평점 3의 부종이 모든 동물에서 관찰되었다. 비광조사부위에서는 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. Ethanol의 야기부위에서는 광조사 유무에 관계없이 홍반, 부종등의 피부반응은 모든 동물에서 관찰되지 않았다. 관찰기간 중, 각 군의 일반증상 및 체중에 대해서 이상은 확인되지 않았다. 이상의 결과로부터, 본시험 조건하에서 시험물질 틸라피아비늘 효소 가수분해물은 광감작성이 없는 물질로 판단된다.Summary and Conclusions: Photosensitization of Tilapia scale enzyme hydrolysates was examined by the Adjuvant & Strip method using Hartley-based male guinea pigs. The group consisted of three groups: test substance group (5), negative control group (5) and positive control group (5). On day 0, the water-FCA emulsion was injected into the four corners of the sensitized area, and then the sensitized area was stripped. 0.1% of 90% test substance, water for injection, and 1.0% chlorpromazine (CP) were applied to the sensitized area of the test substance group, the negative control group and the positive control group, respectively, and then UV-A was irradiated. Stripping, open coating of the administration material, and UV-A irradiation were performed once a day for 5 consecutive days. Yagi was caused by UV-A irradiation on day 21 after administration of 90% test substance and water for injection in test substance and negative control group and 0.1% CP and ethanol in positive control group. Skin reactions were evaluated 24 and 48 hours after firing light irradiation. In the test substance group and the negative control group, skin reactions such as erythema and edema were not observed in all animals at 24 and 48 hours after the irradiated light irrespective of the irradiated area of 90% test substance and water for injection. In the positive control group, erythema of grade 3 and edema of grade 3 were observed in all animals at the irradiation site of 0.1% CP. Skin reactions such as erythema and edema were not observed in all animals. In ethanol-causing areas, skin reactions such as erythema and edema were not observed in all animals with or without light irradiation. During the observation period, no abnormalities were identified for general symptoms and body weight of each group. From the above results, the test substance tilapia scale enzyme hydrolyzate is judged to have no photosensitization under these test conditions.
12. 통계 처리12. Statistical Processing
본 실시예의 실험 및 분석 결과의 통계 처리는 SPSS program(SPSS Inc., Version 12.0)을 사용하여 One-way ANOVA-test를 실시하여 Duncan's multiple range test(Duncan, 1955, P<0.05)로 평균간의 유의성을 검정하였다.Statistical processing of the experimental and analytical results of the present embodiment was carried out using a one-way ANOVA-test using the SPSS program (SPSS Inc., Version 12.0), and the significance between the means by Duncan's multiple range test (Duncan, 1955, P <0.05 ). Was assayed.
13. 화장품 제형13. Cosmetic Formulation
본 발명의 틸라피아 비늘 가수분해물 및 한외 여과 분획물을 포함하는 에센스, 영양크림, 바디로션, 린스, 샴푸, 바디클렌저, 로션, 스킨 및 마스크팩 형태의 화장품을 제조하였다. 구체적인 제조 공정은 도 10a 내지 도 10h 및 도 11a 내지 도 11e에 나타내었다.Cosmetics in the form of essences, nourishing creams, body lotions, rinses, shampoos, body cleansers, lotions, skins and mask packs were prepared comprising the tilapia scale hydrolyzate and ultrafiltration fractions of the present invention. Specific manufacturing processes are shown in FIGS. 10A to 10H and 11A to 11E.
14. 인체 적용 시험14. Human Body Application Test
14-1. 시험 목적14-1. Test purpose
본 시험은 주름이 생성되기 시작하거나 이미 생성된 30세 이상의 여성을 대상으로 12주간 시험제품을 사용하게 하여 제품의 주름개선 효과 및 피부 안전성을 평가하기 위함이다.The purpose of this study is to evaluate the wrinkle-improving effect and skin safety of the product by using the test product for 12 weeks in women who are 30 years old or older or who have already developed wrinkles.
14-2. 시험 제품14-2. Trial product
14-2-1. 시험군 및 대조군14-2-1. Test group and control group
시험군(A): 틸라피아 단백질 펩타이드 1% 함유Test group (A): containing 1% of tilapia protein peptide
대조군(B): 틸라피아 단백질 펩타이드 미함유Control group (B): without tilapia protein peptide
14-2-2. 제품의 성상14-2-2. Characteristics of the product
에센스essence
14-2-3. 제품의 보관14-2-3. Storage of the product
실온 보관Room temperature storage
14-2-4. 제품의 유효 성분14-2-4. Active ingredient of the product
틸라피아 단백질 펩타이드 1% Tilapia Protein Peptide 1%
14-2-5. 제품의 사용 방법 14-2-5. How to use the product
12주 동안 1일 2회(아침, 저녁), 세안 후 스킨 다음단계에서 제품 A와 B를 2번 펌핑하여 볼, 이마, 턱에 나눠놓은 후 부드럽게 펴 바르면서 흡수시켰다. 피험자는 block randomization을 통해 두 그룹으로 나누어 A그룹은 좌측에 시험군(제품 A), 우측에 대조군(제품 B)을 사용하게 하고, B그룹은 좌측에 대조군(제품 B), 우측에 시험군(제품 A)을 사용하게 하였다.Twice a day (morning and evening) for 12 weeks, after washing the skin, the product A and B were pumped twice in the next step, divided into cheeks, forehead, and chin, and gently absorbed. Subjects were divided into two groups through block randomization, and group A used the test group (product A) on the left side, and the control group (product B) on the right side, and group B used the control group (product B) on the left side, and the test group ( Product A) was used.
14-3. 시험 방법14-3. Test Methods
14-3-1. 피험자 선정14-3-1. Subject Selection
본 시험은 30세 이상의 피험자 선정 기준에 부합하고 제외 기준에 부합하지 않는 여성 피험자 20명 이상을 대상으로 하였다. The study was conducted on 20 female subjects who met the criteria for screening subjects over 30 years and did not meet the exclusion criteria.
피부 주름은 더마프로 피부과학연구소의 SOP에 따라 주름이 생성되기 시작 하거나 이미 생성된 피험자를 대상으로 시험의 목적과 방법, 기대 효능과 이상반응을 설명하여 참여의사를 보이는 자는 시험 참가 동의서를 작성하고 시험에 참여하도록 하였다. For skin wrinkles, wrinkles begin to be produced in accordance with SMA of the Dermatological Institute of Dermatology, or those who have indicated their intention to explain the purpose and method, expected efficacy and adverse reactions of the test should be filled out. Participated in the test.
14-3-2. 평가 방법14-3-2. Assessment Methods
평가는 제품 사용 전, 제품 사용 4주, 8주, 12주 후 시점에서 눈꼬리 주름의 육안 평가와 Skin Visiometer® SV600(C+K, Germany)을 이용한 피부 주름 파라미터(R-value) 측정, VISIA®(Canfield, USA)를 이용한 사진 촬영 및 피험 자에 의한 설문평가 그리고 시험자의 관찰과 문진을 통해 피부주름 개선효과 및 피부 안전성을 평가하였다.Evaluation was performed by visual evaluation of crow's feet before and after 4, 8, and 12 weeks of product use and measurement of skin wrinkle parameters (R-value) using Skin Visiometer® SV600 (C + K, Germany), VISIA®. (Canfield, USA) was used to evaluate skin wrinkle improvement and skin safety by taking photographs, evaluating subjects, and investigator observation and questionnaires.
14-4. 통계 분석14-4. Statistical analysis
육안평가 자료 및 기기평가 자료는 SPSS® Package Program (IBM, USA)을 이용하여 유의성을 검증하였다. 동일 피험자에게서 반복 측정한 데이터에 존재하는 상호의존성(교호작용)을 고려하기 위해 반복측정 분산분석법 (Repeated Measures ANOVA)을 적용하였다. Visual and instrumental evaluation data were tested for significance using the SPSS® Package Program (IBM, USA). Repeated Measures ANOVA was applied to take into account the interdependence (interaction) present in repeated measurements from the same subject.
각 시점별 군간 비교는 공분산분석(ANCOVA)을 이용하여 제품 사용 전 두 군간의 차이를 보정하여 확인하였고, 시점별 전후 비교는 RM ANOVA을 이용하여 확인하였다.The comparison between groups at each time point was confirmed by correcting the difference between two groups before using the product using covariance analysis (ANCOVA), and the before and after comparison was confirmed using RM ANOVA.
설문평가 분석시 효능평가는 두 군의 비모수적 평균값을 비교하기 위해 Mann-Whitney U-test를 이용하였고, 사용성 종합평가는 Chi-Square test를 이용하였다. 통계학적 유의수준은 p값을 0.05 미만으로 설정하였다.In the analysis of survey evaluation, the Mann-Whitney U-test was used to compare the nonparametric mean values of the two groups, and the Chi-Square test was used for the comprehensive evaluation. Statistical significance level was set to p value less than 0.05.
14-5. 시험 결과14-5. Test result
14-5-1. 피험자 피부 특성14-5-1. Subject Skin Characteristics
본 시험은 제외기준 및 선정기준에 준하는 30세 이상의 여성 피험자 총 24명(평균 45.6±4.2세)이 시험 종료 시까지 전 과정을 성실히 수행하였다. 피험자의 피부 특성은 설문에 의해 조사되었으며, 분석 결과는 다음과 같다.In this study, a total of 24 female subjects (average 45.6 ± 4.2 years old) over 30 years of age according to the exclusion criteria and selection criteria were conducted in full. The skin characteristics of the subject were examined by a questionnaire, and the analysis results are as follows.
표 3
Figure PCTKR2013010020-appb-T000001
TABLE 3
Figure PCTKR2013010020-appb-T000001
표 4
Figure PCTKR2013010020-appb-T000002
Table 4
Figure PCTKR2013010020-appb-T000002
표 5
Figure PCTKR2013010020-appb-T000003
Table 5
Figure PCTKR2013010020-appb-T000003
14-5-2. 평가 방법14-5-2. Assessment Methods
14-5-2-1. 육안 평가14-5-2-1. Visual evaluation
평가는 10단계(Grade 0~9)로 2명의 시험자가 제품 사용 전과 사용 4주, 8주, 12주 후 시점에서 눈꼬리 부위의 피부 주름 상태를 독립적으로 평가하였다(표 6, 7). '군간'과 '주간변화' 사이에 교호작용이 있는지를 검증하고자 RM ANOVA를 이용하여 분석하였다(표 8, 도 14, 15).The evaluation was performed in 10 stages (Grade 0 ~ 9). Two testers independently evaluated the wrinkled skin condition at the tail of the eye before and after 4, 8, and 12 weeks of use (Tables 6 and 7). RM ANOVA was used to verify whether there was an interaction between 'group' and 'weekly change' (Table 8, Figures 14, 15).
표 6
Figure PCTKR2013010020-appb-T000004
Table 6
Figure PCTKR2013010020-appb-T000004
표 7
Figure PCTKR2013010020-appb-T000005
TABLE 7
Figure PCTKR2013010020-appb-T000005
표 8
Figure PCTKR2013010020-appb-T000006
Table 8
Figure PCTKR2013010020-appb-T000006
각 시점별 군간 차이는 ANCOVA를 이용하여 분석하였고, 각 시점별 전후 변화는 RM ANOVA를 이용하여 통계적 유의성을 확인하였다. Differences between groups at each time point were analyzed using ANCOVA. Changes before and after each time point were confirmed by RM ANOVA for statistical significance.
(1) 각 시점별 군간 비교 (1) Comparison between groups by each time point
분석 결과, 제품 사용 후 모든 평가 시점에서 시험군과 대조군 사이에 유의한 차이는 없었다(표 9). As a result of the analysis, there was no significant difference between the test group and the control group at all evaluation points after product use (Table 9).
표 9
Figure PCTKR2013010020-appb-T000007
Table 9
Figure PCTKR2013010020-appb-T000007
(2) 각 시점별 전후 변화 비교 (2) Comparison of changes before and after each time point
분석 결과, 제품 사용 12주 후 시점에서 시험군의 피부 주름이 다소 감소하는 경향을 보였다(표 10).As a result of the analysis, skin wrinkles of the test group tended to decrease slightly after 12 weeks of use (Table 10).
표 10
Figure PCTKR2013010020-appb-T000008
Table 10
Figure PCTKR2013010020-appb-T000008
14-5-2-2. 주름 파라미터 (R-value) 분석14-5-2-2. Wrinkle parameter (R-value) analysis
제품 사용 전과 사용 4주, 8주, 12주 후 시점에서 Skin Visiometer® SV600을 이용한 시험군과 대조군의 주름 파라미터 R-value (R1~R5)를 측정하여 피부 주름을 평가하였다(표 11).Skin wrinkles were evaluated by measuring the wrinkle parameters R-values (R1-R5) of the test and control groups using the Skin Visiometer® SV600 at 4, 8, and 12 weeks before and after the use of the product (Table 11).
표 11
Figure PCTKR2013010020-appb-T000009
Table 11
Figure PCTKR2013010020-appb-T000009
'군간'과 '주간변화' 사이에 교호작용이 있는를 검증하고자 RM ANOVA를 이용하여 분석하였다(표 12, 도 16 내지 20).In order to verify that there is an interaction between 'group' and 'weekly change', it was analyzed using RM ANOVA (Table 12, FIGS. 16 to 20).
표 12
Figure PCTKR2013010020-appb-T000010
Table 12
Figure PCTKR2013010020-appb-T000010
5가지 주름 파라미터(R1~R5) 모두 Group*Week (군간*주간변화)의 교호작용은 유의하게 나타나지 않았지만 시점별(WEEK)로 유의한 차이가 있음을 알 수 있었다. In all five wrinkle parameters (R1 ~ R5), the interaction between Group * Week (group * weekly change) was not significant, but there was a significant difference by time (WEEK).
각 시점별 군간 차이는 ANCOVA를 이용하여 분석하였고, 각 시점별 전후 변화는 RM ANOVA를 이용하여 통계적 유의성을 확인하였다.Differences between groups at each time point were analyzed using ANCOVA. Changes before and after each time point were confirmed by RM ANOVA for statistical significance.
(1) 각 시점별 군간 비교 (1) Comparison between groups by each time point
분석 결과, 제품 사용 12주 후 시점에서 파라미터 중 R1은 시험군이 대조군에 비해 유의하게 감소하였으며(p<0.05), 나머지 파라미터(R2, R3, R4, R5)에서 군간 유의차는 없었다(표 13, 도 16 내지 20).As a result, at 12 weeks after the product use, the R1 of the parameters was significantly decreased in the test group compared to the control group (p <0.05), and there was no significant difference between the groups in the remaining parameters (R2, R3, R4, R5) (Table 13, 16-20).
표 13
Figure PCTKR2013010020-appb-T000011
Table 13
Figure PCTKR2013010020-appb-T000011
(2) 각 시점별 전후 변화 비교 (2) Comparison of changes before and after each time point
분석 결과, 시험군의 경우 파라미터 중 R2는 제품 사용 4주, 12주 후 시점에서, R1, R3, R4, R5는 제품 사용 12주 후 시점에서 유의하게 감소하였으며, 대조군은 파라미터 중 R2, R5가 제품 사용 12주 후 시점에서 유의하게 감소하였다(p<0.05, 표 14, 도 16 내지 20). As a result, in the test group, R2 was significantly decreased at 4 weeks and 12 weeks after using the product, and R1, R3, R4 and R5 were significantly decreased at 12 weeks after using the product. Significant decrease was found after 12 weeks of product use (p <0.05, Table 14, FIGS. 16-20).
표 14
Figure PCTKR2013010020-appb-T000012
Table 14
Figure PCTKR2013010020-appb-T000012
14-5-2-3. 효능 및 사용성에 관한 설문 분석 14-5-2-3. Survey analysis on efficacy and usability
제품 사용 후 각 시점에서 피험자들이 작성한 효능에 관한 설문과 제품 사용성 종합 설문에 관한 평가를 종합하였다.At each time point after the use of the product, the questionnaire about the efficacy of the subjects and the evaluation on the comprehensive product usability questionnaire were combined.
(1) 효능에 관한 설문 평가 (1) Evaluation of questionnaire about efficacy
평가 결과, '촉촉해짐', '부드러움' 항목은 제품 사용 12주 후 시점에서 시험군과 대조군 모두 피험자의 79~88%가 긍정적으로 응답하였다. 모든 항목에서 군간 유의차는 없었다(표 15~19, 도 21 내지 25).As a result of the evaluation, 79 to 88% of the subjects in the test group and the control group responded positively at the time of 'moist' and 'soft'. There was no significant difference between groups in all items (Tables 15-19, Figures 21-25).
표 15
Figure PCTKR2013010020-appb-T000013
Table 15
Figure PCTKR2013010020-appb-T000013
표 16
Figure PCTKR2013010020-appb-T000014
Table 16
Figure PCTKR2013010020-appb-T000014
표 17
Figure PCTKR2013010020-appb-T000015
Table 17
Figure PCTKR2013010020-appb-T000015
표 18
Figure PCTKR2013010020-appb-T000016
Table 18
Figure PCTKR2013010020-appb-T000016
표 19
Figure PCTKR2013010020-appb-T000017
Table 19
Figure PCTKR2013010020-appb-T000017
(2) 사용성에 관한 설문 평가 (2) Survey evaluation about usability
평가 결과, '색', '향', '흡수력', '만족도' 항목에서 시험군과 대조군 모두 58~88%의 피험자가 긍정적으로 응답하였다(표 20, 도 26). As a result of the evaluation, 58 to 88% of the subjects in the test group and the control group responded positively in the items of 'color', 'flavor', 'absorbency' and 'satisfaction' (Table 20, FIG. 26).
표 20
Figure PCTKR2013010020-appb-T000018
Table 20
Figure PCTKR2013010020-appb-T000018
14-5-3. 피부 안전성 평가 14-5-3. Skin safety assessment
본 시험기간 동안 모든 피험자에게서 피부 이상반응은 관찰되지 않았다(표 21). No skin adverse events were observed in all subjects during this study (Table 21).
표 21
Figure PCTKR2013010020-appb-T000019
Table 21
Figure PCTKR2013010020-appb-T000019

Claims (4)

  1. 틸라피아(Tilapia mossambica) 비늘 추출물의 효소적 가수분해물을 포함하는 화장품 조성물.Cosmetic composition comprising an enzymatic hydrolyzate of Tilapia mossambica scale extract.
  2. 제 1항에 있어서, The method of claim 1,
    상기 효소적 가수분해물은 다음의 단계들을 포함하여 제조되는 것을 특징으로 하는 화장품 조성물:The enzymatic hydrolyzate is a cosmetic composition comprising the following steps:
    (S1) 틸라피아 비늘을 수세 후 원적외선으로 건조시키는 단계;(S1) drying the tilapia scales in far infrared rays after washing with water;
    (S2) 건조된 틸라피아 비늘을 열수 추출하는 단계;(S2) hydrothermally extracting the dried tilapia scales;
    (S3) 열수 추출된 틸라피아 비늘을 효소적 가수분해시키는 단계;(S3) enzymatic hydrolysis of the hydrothermally extracted tilapia scales;
    (S4) 틸라피아 비늘의 효소적 가수분해물을 활성탄 여과시키는 단계;(S4) activated carbon filtration of the enzymatic hydrolyzate of the tilapia scales;
    (S5) 활성탄 여과물을 0.4~0.5μm의 여과막으로 여과시키는 단계;(S5) filtering the activated carbon filtrate with a 0.4 to 0.5 μm filtration membrane;
    (S6) 0.4~0.5μm의 여과막에 의한 여과물을 이온교환수지막으로 여과시키는 단계;(S6) filtering the filtrate by the filter membrane of 0.4 ~ 0.5μm with an ion exchange resin membrane;
    (S7) 이온교환수지막 여과물을 한외여과막으로 분획하는 단계; 및 (S7) fractionating the ion exchange resin membrane filtrate into an ultrafiltration membrane; And
    (S8) 분획물을 농축 후 동결건조 및 분쇄하는 단계.(S8) lyophilization and milling of the fractions after concentration.
  3. 제 2항에 있어서,The method of claim 2,
    상기 효소적 가수분해는 α-키모트립신(α-chymotrypsin), 알칼라아제(alcalase), 코지자임(Kojozyme), 프로타멕스(Protamex) 및 트립신(Trypsin)으로 이루어지는 군으로부터 선택되는 것을 특징으로 하는 화장품 조성물.The enzymatic hydrolysis is characterized in that selected from the group consisting of α-chymotrypsin (α-chymotrypsin), alcalase (alcalase), Kojozyme, Protamex (Trytamin) and trypsin (Trypsin) Cosmetic composition.
  4. 제 1항 내지 제 3항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 3,
    상기 화장품 조성물은 항산화, 주름개선 및 미백 효과를 나타내는 것을 특징으로 하는 화장품 조성물.The cosmetic composition is characterized in that the antioxidant, anti-wrinkle and whitening effect cosmetic composition.
PCT/KR2013/010020 2013-05-01 2013-11-06 Functional cosmetic composition comprising enzymatic hydrolysate of tilapia mossambica scales WO2014178501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130049057A KR101514988B1 (en) 2013-05-01 2013-05-01 A cosmetic composition comprising enzymatic extracts from tilapia mossambica
KR10-2013-0049057 2013-05-01

Publications (1)

Publication Number Publication Date
WO2014178501A1 true WO2014178501A1 (en) 2014-11-06

Family

ID=51843608

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/010020 WO2014178501A1 (en) 2013-05-01 2013-11-06 Functional cosmetic composition comprising enzymatic hydrolysate of tilapia mossambica scales

Country Status (2)

Country Link
KR (1) KR101514988B1 (en)
WO (1) WO2014178501A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114671937A (en) * 2022-03-18 2022-06-28 大连工业大学 Polypeptide with tyrosinase inhibitory activity and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100439493B1 (en) * 1998-12-31 2004-07-09 에스케이더블유 바이오시스템즈 Process for the preparation of fish gelatin
KR20120021590A (en) * 2010-08-10 2012-03-09 (주)청룡수산 A pharmaceutical composition for prevention or treatment of hypertension comprising enzymatic extracts from tilapia mossambica as an effective component
KR101131223B1 (en) * 2010-07-30 2012-03-28 부경대학교 산학협력단 Antioxidant peptide isolated from Nile tilapia and antioxidant composition comprising of the same
US20120114570A1 (en) * 2008-12-23 2012-05-10 Universiti Putra Malaysia Collagen extraction from aquatic animals

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100439493B1 (en) * 1998-12-31 2004-07-09 에스케이더블유 바이오시스템즈 Process for the preparation of fish gelatin
US20120114570A1 (en) * 2008-12-23 2012-05-10 Universiti Putra Malaysia Collagen extraction from aquatic animals
KR101131223B1 (en) * 2010-07-30 2012-03-28 부경대학교 산학협력단 Antioxidant peptide isolated from Nile tilapia and antioxidant composition comprising of the same
KR20120021590A (en) * 2010-08-10 2012-03-09 (주)청룡수산 A pharmaceutical composition for prevention or treatment of hypertension comprising enzymatic extracts from tilapia mossambica as an effective component

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AHN, YONG SEOK: "Biological Activity of Branchiostegus japonicus and Tilapia mossambica Scale Prepared by Enzymatic Hydrolysis", JEJU NATIONAL UNIVERSITY DOCTORAL THESIS, February 2010 (2010-02-01) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114671937A (en) * 2022-03-18 2022-06-28 大连工业大学 Polypeptide with tyrosinase inhibitory activity and preparation method thereof

Also Published As

Publication number Publication date
KR20140130597A (en) 2014-11-11
KR101514988B1 (en) 2015-04-24

Similar Documents

Publication Publication Date Title
Aguilar-Toalá et al. Potential role of natural bioactive peptides for development of cosmeceutical skin products
KR100613554B1 (en) Cosmetics
US11503840B2 (en) Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same
EP0149872B1 (en) Cosmetic composition containing glycoproteins for the skin care
US20070116659A1 (en) Elastase inhibitor
WO2014178500A1 (en) Functional cosmetic composition comprising enzymatic hydrolysate of branchiostegus japonicus scales
WO2016013709A1 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
KR20150096800A (en) Cosmetic composition from fish hatching fluid
Yadav et al. Potential role of peptides for development of cosmeceutical skin products
WO2020235941A1 (en) Spray composition for improving scalp health containing eoseongcho component
US20030232043A1 (en) Compositions and methods for softening, thinning and removing hyperkeratotic tissue
JP7357983B2 (en) Extract of Moringa peregrina seed solids, method for obtaining same and use thereof in cosmetic product compositions or nutricosmetic compositions
KR101721944B1 (en) A cosmetic composition comprising enzymatic extracts from soft coral
WO2014178501A1 (en) Functional cosmetic composition comprising enzymatic hydrolysate of tilapia mossambica scales
KR101414150B1 (en) Cosmetic compositions for anti-wrinkle effect comprising hydrolyzed placenta extract using high pressure system
WO2017142265A1 (en) Composition containing adipic acid as active ingredient for skin wrinkle alleviation and skin elasticity enhancement
WO2018111042A2 (en) Cosmetic composition comprising extract of medicinal herbs as active ingredient
KR101585913B1 (en) Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone
KR20200016813A (en) Composition for skin whitening comprising enzymatic hydrolysates of insect
KR101853927B1 (en) A cosmetic composition comprising enzymatic hydrolysate of salmon scaled with the excellent effect of skin exfoliation efficacy, itching improvement and scalp dandruff improvemtny
WO2016122091A1 (en) Pharmaceutical composition for prevention and treatment of allergic disease or contact dermatitis, comprising cymbidium extract as active ingredient
WO2021107381A1 (en) Composition comprising ferulic acid and analogs thereof for preventing and treating skin diseases caused by genetic mutation
Ebenebe et al. Arthropods in Cosmetics, Pharmaceuticals and Medicine: A Review
FR2915385A1 (en) USE OF AN ACTIVE INGREDIENT FROM AMARANTE (AMARANTHUS) FOR PREPARING A COMPOSITION FOR ACTIVATING CELL ENERGY AND PROTECTING THE SKIN FROM OXIDATIVE DAMAGE.
WO2019168262A1 (en) Fermented sunfish extract, cosmetic material composition comprising same, and preparation method therefor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13883455

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13883455

Country of ref document: EP

Kind code of ref document: A1